<SEC-DOCUMENT>0001193125-26-052164.txt : 20260217
<SEC-HEADER>0001193125-26-052164.hdr.sgml : 20260217
<ACCEPTANCE-DATETIME>20260213214123
ACCESSION NUMBER:		0001193125-26-052164
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20260212
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260217
DATE AS OF CHANGE:		20260213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cineverse Corp.
		CENTRAL INDEX KEY:			0001173204
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-VIDEO TAPE RENTAL [7841]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				223720962
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31810
		FILM NUMBER:		26635782

	BUSINESS ADDRESS:	
		STREET 1:		224 W. 35TH ST.
		STREET 2:		SUITE 500, #947
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001
		BUSINESS PHONE:		212-206-8600

	MAIL ADDRESS:	
		STREET 1:		224 W. 35TH ST.
		STREET 2:		SUITE 500, #947
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cinedigm Corp.
		DATE OF NAME CHANGE:	20130925

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cinedigm Digital Cinema Corp.
		DATE OF NAME CHANGE:	20091006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Access Integrated Technologies, Inc. d/b/a Cinedigm Digital Cinema Corp.
		DATE OF NAME CHANGE:	20081202
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d910663d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnvs="http://cineverse.com/20260212" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-296">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-02-12_to_2026-02-12">0001173204</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cnvs-20260212.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-02-12_to_2026-02-12"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001173204</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-02-12</xbrli:startDate> <xbrli:endDate>2026-02-12</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:7pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-307">8-K</ix:nonNumeric></span></p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:7pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:7pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt:datemonthdayyearen" id="ixv-308">February&#160;12, 2026</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Date of earliest event reported)</p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:7pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-309">Cineverse Corp.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:stateprovnameen" id="ixv-310">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-311">001-31810</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-312">22-3720962</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-75">237 West 35<sup style="font-size:75%; vertical-align:top">th</sup> Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-313">Suite 500</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-314">#947</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-315">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:stateprovnameen" id="ixv-316">New York</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-317">10001</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-318">212</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-319">206-8600</ix:nonNumeric></span></span></p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:7pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see </span>General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:boolballotbox" id="ixv-320">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:boolballotbox" id="ixv-321">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:boolballotbox" id="ixv-322">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:boolballotbox" id="ixv-323">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:boolballotbox" id="ixv-324">&#9744;</ix:nonNumeric></p> <p style="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transmission period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="margin-top:7pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:7pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-325">CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-326">CNVS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2026-02-12_to_2026-02-12" format="ixt-sec:exchnameen" id="ixv-327">The Nasdaq Stock Market</ix:nonNumeric></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Definitive Material Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;12, 2026, Cineverse Corp. (the &#8220;Company&#8221;) agreed to sell in a public offering an aggregate of 1,500,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s Class&#160;A common stock (the &#8220;Common Stock&#8221;), at a purchase price of $2.00 per share, for aggregate gross proceeds of approximately $3.0&#160;million, before deducting underwriting commissions and expenses payable by the Company (the &#8220;Offering&#8221;). We have granted to the Underwriter an option to purchase up to an additional 225,000 shares (&#8220;Option Shares&#8221; and, together with the Shares, the &#8220;Offered Shares&#8221;) of common stock from us at the same price to the public, and with the same underwriting discount. The Offered Shares will be sold pursuant to an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with The Benchmark Company, LLC (the &#8220;Underwriter&#8221;) and pursuant a prospectus and prospectus supplement which are part of the Company&#8217;s shelf registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-273098)</span> filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing of the sale of the Shares is expected to occur on or about February&#160;17, 2026, subject to the satisfaction of customary closing conditions. The net proceeds to the Company from the sale of the Shares, after deducting the fees of the underwriter but before paying the Company&#8217;s estimated Offering expenses, is approximately $2.8&#160;million (or $3.2, if the Underwriter exercises its option to purchase all of the Option Shares). The Company intends to use the net proceeds from the sale of the Offered Shares for working capital and for other general corporate purposes, including the financing of content acquisition and development. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;13, 2026, the Underwriter exercised its option to purchase the Option Shares in full. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Benchmark Company, LLC, is acting as sole underwriter for the Offering. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The opinion of Kelley Drye&#160;&amp; Warren LLP regarding the validity of the Offered Shares sold in the Offering is attached hereto as Exhibit 5.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;12, 2026, the Company issued a press release announcing the Offering, a copy of which is attached hereto as Exhibit 99.1 and a press release announcing the pricing of the Offering, a copy of which is attached hereto as Exhibit 99.2. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to, and incorporate herein by reference, the full text thereof, a copy of which is filed herewith as Exhibit 1.1. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d910663dex11.htm">Underwriting Agreement dated February&#160;12, 2026. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d910663dex51.htm">Opinion of Kelley Drye&#160;&amp; Warren LLP. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d910663dex51.htm">Consent of Kelley Drye&#160;&amp; Warren LLP (included in Exhibit&#160;5.1 hereto). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d910663dex991.htm">Press Release dated February 12, 2026. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d910663dex992.htm">Press Release dated February&#160;12, 2026. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of Section&#160;13 or 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Dated: February&#160;13, 2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Gary S. Loffredo</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Gary S. Loffredo</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer, Secretary and Senior Advisor</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d910663dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CINEVERSE CORP. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1,500,000 Shares
of Class&nbsp;A Common Stock, par value $0.001 per share </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Underwriting Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">February&nbsp;12, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE BENCHMARK COMPANY,
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">150 E 58<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> St., Floor #17 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10155 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cineverse Corp., a Delaware corporation (the &#8220;Company&#8221;), proposes to issue and sell to The Benchmark Company, LLC, in its capacity
as underwriter (the &#8220;Underwriter&#8221;), an aggregate of 1,500,000&nbsp;shares (the &#8220;Underwritten Shares&#8221;) of Class&nbsp;A Common Stock, par value $0.001 per share (&#8220;Common Stock&#8221;), of the Company and, at the option of
the Underwriter, up to an additional 225,000&nbsp;shares of Common Stock (the &#8220;Option Shares&#8221;). The Underwritten Shares and the Option Shares are herein referred to as the &#8220;Shares.&#8221; The shares of Common Stock to be
outstanding after giving effect to the sale of the Shares are referred to herein as the &#8220;Stock.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby confirms
its agreement with the Underwriter concerning the purchase and sale of the Shares, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The
Company has prepared and filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;Securities
Act&#8221;), a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-273098),</FONT> including a prospectus, relating to certain securities of the Company, including the
Shares. Such registration statement, as amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its
effectiveness (&#8220;Rule 430 Information&#8221;), is referred to herein as the &#8220;Registration Statement&#8221;; and as used herein, the term &#8220;Preliminary Prospectus&#8221; means each prospectus included in such registration statement
(and any amendments thereto) before effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act, the prospectus included in the Registration Statement at the time of its effectiveness that omits Rule 430
Information (the &#8220;Base Prospectus&#8221;) and the prospectus supplement dated February&nbsp;12, 2026 relating to the Shares, and the term &#8220;Prospectus&#8221; means the Base Prospectus and the prospectus supplement in the form first used
(or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under the
Securities Act (the &#8220;Rule 462 Registration Statement&#8221;), then any reference herein to the term &#8220;Registration Statement&#8221; shall be deemed to include such Rule 462 Registration Statement. Any reference in this underwriting
agreement (this &#8220;Agreement&#8221;) to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, as of the effective date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#8220;amend,&#8221;
&#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed after such date under the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#8220;Exchange Act&#8221;) that are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the
meanings given to such terms in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the Applicable Time (as defined below), the
Company had prepared the following information (collectively with the pricing information set forth on Annex A, the &#8220;Pricing Disclosure Package&#8221;): a Preliminary Prospectus dated February&nbsp;12, 2026 and each &#8220;free-writing
prospectus&#8221; (as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Applicable Time&#8221; means 9:00&nbsp;P.M., New York City time, on February&nbsp;12,
2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Company agrees to issue and sell the Underwritten Shares to the Underwriter as provided in this Agreement, and the Underwriter, on the
basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees to purchase at a price per Share of $1.8803 (the &#8220;Purchase Price&#8221;) from the Company the number of
Underwritten Shares set forth opposite the Underwriter&#8217;s name in Schedule 1 hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Company agrees to issue and
sell the Option Shares to the Underwriter as provided in this Agreement, and the Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to
purchase from the Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company and payable on the Underwritten Shares but not payable on the Option Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriter may exercise the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the
thirtieth day following the date of the Prospectus, by written notice from the Underwriter to the Company. Such notice shall set forth the aggregate number of Option Shares as to which the option is being exercised and the date and time when the
Option Shares are to be delivered and paid for, which may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than the tenth full business day (as hereinafter defined) after
the date of such notice. Any such notice shall be given at least two business days prior to the date and time of delivery specified therein, provided that if such date and time of delivery are the same as the Closing Date, such notice may be given
one business day prior to such date and time of delivery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company understands that the Underwriter intends to make a public
offering of the Shares, and initially to offer the Shares on the terms set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriter may offer and sell Shares to or through any affiliate of the Underwriter.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the
Underwriter in the case of the Underwritten Shares, at the offices of Faegre Drinker Biddle&nbsp;&amp; Reath LLP, counsel for the Underwriter, at 200 Wells Fargo Center 90 S. Seventh Street, Minneapolis, Minnesota 55402 at 10:00 A.M. New York City
time on February&nbsp;17, 2026, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Underwriter and the Company may agree upon in writing or, in the case of the Option Shares, on
the date and at the time and place specified by the Underwriter in the written notice of the Underwriter&#8217;s election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the
&#8220;Closing Date,&#8221; and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the &#8220;Additional Closing Date.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery
to the Underwriter of the Shares to be purchased on such date or the Additional Closing Date, as the case may be, with any transfer taxes payable in connection with the sale of such Shares duly paid by the Company. Delivery of the Shares shall be
made in book-entry form registered in such names and in such denominations as the Underwriter shall request in writing not later than two full business days prior to the Closing Date or Additional Closing Date, as applicable, through the facilities
of The Depository Trust Company (&#8220;DTC&#8221;) unless the Underwriter shall otherwise instruct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company acknowledges and
agrees that the Underwriter is acting solely in the capacity of an arm&#8217;s length contractual counterparty to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the
offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, the Underwriter is not advising the Company or any other person as to any legal, tax, investment, accounting or regulatory
matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Underwriter
shall not have any responsibility or liability to the Company with respect thereto. Any review by the Underwriter of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the
benefit of the Underwriter and shall not be on behalf of the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of the Company</U>. The Company represents and warrants
to the Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Compliance with Registration Requirements</I>. The Registration Statement has become effective under the
Securities Act. The Company has complied, to the Commission&#8217;s satisfaction with all requests of the Commission for additional or supplemental information, if any. No stop order suspending the effectiveness of the Registration Statement is in
effect and no proceedings for such purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering of the Shares have been instituted or are pending or, to the best knowledge of the Company, are
contemplated or threatened by the Commission. At the time the Company&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended March&nbsp;31, 2025 (the &#8220;Annual Report&#8221;) was filed with the Commission,
or, if later, at the time the Registration Statement was originally filed with the Commission, the Company met the then-applicable requirements for use of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act. The Company meets
the requirements for use of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act specified in Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Conduct Rule 5110(h)(1)(C). The documents incorporated or deemed
to be incorporated by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus, at the time they were or hereafter are filed with the Commission, or became effective under the Exchange Act, as the case may be,
complied and will comply in all material respects with the requirements of the Exchange Act, and none of such documents contained any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and any further documents so filed and incorporated by reference in the Registration Statement, the Prospectus or the Pricing Disclosure Package, when such documents are
filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Disclosure</I>. Each Preliminary Prospectus and the
Prospectus when filed complied in all material respects with the Securities Act and, if filed by electronic transmission pursuant to the Commission&#8217;s Electronic Data Gathering Analysis and Retrieval system (&#8220;EDGAR&#8221;), was identical
(except as may be permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> under the Securities Act) to the copy thereof delivered to the Underwriter for use in connection with the offer and sale of the Shares. Each of the Registration
Statement and any post-effective amendment thereto, at the time it became or becomes effective, complied and will comply in all material respects with the Securities Act and did not and will not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. As of the Applicable Time, the Pricing Disclosure Package (including any preliminary prospectus wrapper) did not, and at the
Closing Date and at each applicable Additional Closing Date, will not, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The Prospectus (including any Prospectus wrapper), as of its date, did not, and at the Closing Date and at each applicable Additional Closing Date, will not, contain any untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The representations and warranties set forth in the three immediately preceding sentences do not apply to
statements in or omissions from the Registration Statement or any post-effective amendment thereto, or the Prospectus or the Pricing Disclosure Package, or any amendments or supplements thereto, made in reliance upon and in conformity with written
information relating to any Underwriter furnished to the Company in writing by the Underwriter expressly for use therein, it being understood and agreed that the only such information consists of the information described in Section&nbsp;7(b) below.
There are no contracts or other documents required to be described in the Pricing Disclosure Package or the Prospectus or to be filed as an exhibit to the Registration Statement which have not been described or filed as required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Free Writing Prospectuses; Road Show</I>. As of the determination date referenced in Rule 164(h) under the Securities Act, the Company
was not, is not or will not be (as applicable) an &#8220;ineligible issuer&#8221; in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act. Each free writing prospectus that the Company is required to
file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act. Each free writing prospectus that the Company has filed, or is required to file,
pursuant to Rule 433(d) under the Securities Act or that was prepared </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of Rule 433 under the Securities Act, including timely filing with
the Commission or retention where required and legending, and each such free writing prospectus, as of its issue date and at all subsequent times through the completion of the public offer and sale of the Shares did not, does not and will not
include any information that conflicted, conflicts or will conflict with the information contained in the Registration Statement, the Prospectus or any preliminary prospectus and not superseded or modified. Each free writing prospectus, when
considered together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. Except for the free writing prospectuses, if any, identified in Annex A hereto, electronic road shows, if any, furnished to the Underwriter before first use, and any document not constituting a prospectus
pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act (an &#8220;Issuer Free Writing Prospectus&#8221;), the Company has not prepared, used or referred to, and will not, without the Underwriter&#8217;s prior
written consent, which consent shall not be unreasonably withheld, prepare, use or refer to, any free writing prospectus. Each road show, when considered together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Distribution of Offering Material By the Company</I>. Prior to the latest of (i)&nbsp;the expiration or termination of the option
granted to the Underwriter in Section&nbsp;2 and (ii)&nbsp;the completion of the Underwriter&#8217;s distribution of the Shares, the Company has not distributed and will not distribute any offering material in connection with the offering and sale
of the Shares other than the Registration Statement, the Pricing Disclosure Package, the Prospectus or any free writing prospectus reviewed and consented to by the Underwriter, which consent shall not be unreasonably withheld, the free writing
prospectuses, if any, identified on Annex A hereto and any oral or written communication with potential investors undertaken in reliance on either Section&nbsp;5(d) of, or Rule 163B under, the Securities Act (each, a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#8220;Testing-the-Waters</FONT></FONT> Communication&#8221; and, if a written communication, a &#8220;Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication&#8221;). The Company has not distributed or approved for distribution any Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications other than those listed on Annex B hereto. Each Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, when
considered together with the Pricing Disclosure Package, did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>The Underwriting Agreement</I>. This Agreement has been duly authorized, executed and
delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Authorization of the Shares</I>. (i)&nbsp;The Shares have been duly authorized for issuance and sale
pursuant to this Agreement and, when issued and delivered by the Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable; and (ii)&nbsp;and the issuance and sale of the Shares is not subject
to any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>No Applicable
Registration or Other Similar Rights</I>. There are no persons with registration or other similar rights to have any equity or debt securities registered for sale under the Registration Statement or included in the offering contemplated by this
Agreement, except for such rights as have been duly waived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>No Material Adverse Change</I>. Except as otherwise disclosed in the
Registration Statement, the Pricing Disclosure Package and the Prospectus, subsequent to the respective dates as of which information is given in the Registration Statement, the Pricing Disclosure Package and the Prospectus: (i)&nbsp;there has been
no material adverse change, or any development that would reasonably be expected to result in a material adverse change, in the condition, financial or otherwise, or in the earnings, business, properties, operations, assets, liabilities or
prospects, whether or not arising from transactions in the ordinary course of business, of the Company and its subsidiaries, considered as one entity (any such change being referred to herein as a &#8220;Material Adverse Change&#8221;); (ii) the
Company and its subsidiaries, considered as one entity, have not incurred any material liability or obligation, indirect, direct or contingent, including without limitation any losses or interference with its business from fire, explosion, flood,
earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree, that are material, individually or in the aggregate, to the Company and its
subsidiaries, considered as one entity, or has entered into any transactions not in the ordinary course of business; and (iii)&nbsp;there has not been any material decrease in the capital stock or any material increase in any short-term or long-term
indebtedness of the Company or its subsidiaries and there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for dividends paid to the Company or other subsidiaries, by the Company&#8217;s subsidiaries
on any class of capital stock, or any repurchase or redemption by the Company or its subsidiaries of any class of capital stock. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Independent Accountants</I>. EisnerAmper LLP, which has expressed its opinion with
respect to the Company financial statements (which term as used in this Agreement includes the related notes thereto) filed with the Commission as a part of the Registration Statement, the Pricing Disclosure Package and the Prospectus, is
(i)&nbsp;an independent registered public accounting firm as required by the Securities Act, the Exchange Act, and the rules of the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;), (ii) in compliance with the applicable requirements
relating to the qualification of accountants under Rule <FONT STYLE="white-space:nowrap">2-01</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Securities Act and (iii)&nbsp;a registered public accounting firm as defined by
the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)
<I>Financial Statements</I>. The Company financial statements filed with the Commission as a part of the Registration Statement, the Pricing Disclosure Package and the Prospectus present fairly, in all material respects, the consolidated financial
position of the Company and its subsidiaries as of the dates indicated and the results of their operations, changes in stockholders&#8217; equity and cash flows for the periods specified. Such financial statements have been prepared in conformity
with generally accepted accounting principles as applied in the United States (&#8220;GAAP&#8221;), applied on a consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto. All disclosures
contained in the Registration Statement, any preliminary prospectus or the Prospectus and any free writing prospectus, that constitute <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures (as defined by the rules and regulations under
the Securities Act and the Exchange Act) comply with Regulation G under the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, as applicable. To the Company&#8217;s knowledge, no person who
has been suspended or barred from being associated with a registered public accounting firm, or who has failed to comply with any sanction pursuant to Rule 5300 promulgated by the PCAOB, has participated in or otherwise aided the preparation of, or
audited, the financial statements, supporting schedules or other financial data filed with the Commission as a part of the Registration Statement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Company&#8217;s Accounting System</I>. The Company and its subsidiaries make and keep accurate books and records and maintain a system
of internal accounting controls sufficient to provide reasonable assurance that: (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific authorization; (ii)&nbsp;transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii)&nbsp;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv)&nbsp;the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v)&nbsp;the interactive data in eXtensible Business Reporting Language included or incorporated
by reference in the Registration Statement, the Pricing Disclosure Package and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines
applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Disclosure Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial
Reporting</I>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company has established and maintains disclosure controls and procedures (as defined in Rules
<FONT STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15</FONT> under the Exchange Act), which (i)&nbsp;are designed to ensure that material information relating to the Company, including its consolidated
subsidiaries, is made known to the Company&#8217;s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange Act are
being prepared; (ii)&nbsp;have been evaluated by management of the Company for effectiveness as of the end of the Company&#8217;s most recent fiscal quarter; and (iii)&nbsp;are effective in all material respects to perform the functions for which
they were established. Since the end of the Company&#8217;s most recent audited fiscal year, there have been no significant deficiencies or material weakness in the Company&#8217;s internal control over financial reporting (whether or not
remediated) and no change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. The Company is not
aware of any change in its internal control over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over
financial reporting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Incorporation and Good Standing of the Company</I>. The Company has been duly
incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware and has the corporate power and authority to own, lease and operate its properties and to conduct its business as described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus and to enter into and perform its obligations under this Agreement. The Company is duly qualified as a foreign corporation to transact business and is in good standing in each
jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or in good standing, as the case may be, or to have such power or
authority would not, individually or in the aggregate, have a Material Adverse Effect (defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Subsidiaries</I>. The
Company&#8217;s &#8220;subsidiaries&#8221; (for purposes of this Agreement, as defined in Rule 405 under the Securities Act) have been duly incorporated or organized, as the case may be, and are validly existing and in good standing (where such
concept is recognized) under the laws of the jurisdiction of its incorporation or organization and have the power and authority (corporate or other) to own, lease and operate their properties and to conduct their business as described in the
Registration Statement, the Pricing Disclosure Package and the Prospectus. The Company&#8217;s subsidiaries are duly qualified to transact business and are in good standing (where such concept is recognized) in each jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to be so qualified or in good standing, as the case may be, or have such power or authority would not,
individually or in the aggregate, have a Material Adverse Effect. All of the issued and outstanding capital stock or other equity or ownership interests of the Company&#8217;s subsidiaries have been duly authorized and validly issued, are fully paid
and nonassessable and are owned by the Company, free and clear of any security interest, mortgage, pledge, lien, encumbrance or adverse claim, except as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The
Company does not own or control, directly or indirectly, any corporation, association or other entity other than the subsidiaries listed in Exhibit 21.1 to the Annual Report. The subsidiaries listed in Schedule 2 to this Agreement are the only
significant subsidiaries of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>Capitalization and Other Capital Stock Matters</I>. The authorized, issued and
outstanding capital stock of the Company is as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus (other than for subsequent issuances, if any, pursuant to employee benefit plans, or upon the exercise of
outstanding options or warrants, in each case described in the Registration Statement, the Pricing Disclosure Package and the Prospectus). The Shares, when issued pursuant to the terms of this Agreement will conform, in all material respects, to the
description thereof contained in the Pricing Disclosure Package. All of the issued and outstanding shares of Common Stock have been duly authorized and validly issued, are fully paid and nonassessable and have been issued in compliance with all
applicable federal and state securities laws. None of the outstanding shares of Common Stock were issued in violation of any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase securities of the Company.
There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or
its subsidiaries other than those described in the Registration Statement, the Pricing Disclosure Package and the Prospectus. The descriptions of the Company&#8217;s stock option, stock bonus and other stock plans or arrangements (each, a
&#8220;Company Stock Plan&#8221;), and the options or other rights granted thereunder, set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus accurately and fairly presents, in all material respects, the
information required to be shown with respect to such plans, arrangements, options and rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>Stock Exchange Listing</I>. The
Common Stock is registered pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act and is listed on The Nasdaq Stock Market (the &#8220;Nasdaq&#8221;), and the Company has taken no action designed to, or likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act or delisting the Common Stock from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. To the
Company&#8217;s knowledge, it is in compliance with all applicable listing requirements of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)
<I><FONT STYLE="white-space:nowrap">Non-Contravention</FONT> of Existing Instruments; No Further Authorizations or Approvals Required</I>. Neither the Company nor its subsidiaries is in violation of its charter or
<FONT STYLE="white-space:nowrap">by-laws,</FONT> partnership agreement or operating agreement or similar organizational documents, as applicable, or is in default (or, with the giving of notice or lapse of time, would be in default)
(&#8220;Default&#8221;) under any indenture, loan, credit agreement, note, lease, license agreement, contract, franchise or other instrument (including, without limitation, any pledge agreement, security agreement,
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company or its subsidiaries is a party or by which it or any of them may be
bound, or to which any of their respective properties or assets are subject (each, an &#8220;Existing Instrument&#8221;), except for such Defaults as could not be expected, individually or in the aggregate, to have a material adverse effect on the
condition (financial or other), earnings, business, properties, operations, assets, liabilities or prospects of the Company and its subsidiaries, considered as one entity (a &#8220;Material Adverse Effect&#8221;). The Company&#8217;s execution,
delivery and performance of this Agreement, consummation of the transactions contemplated hereby and by the Registration Statement, the Pricing Disclosure Package and the Prospectus and the issuance and sale of the Shares (including the use of
proceeds from the sale of the Shares as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus under the caption &#8220;Use of Proceeds&#8221;) (i) have been duly authorized by all necessary corporate action and
will not result in any violation of the provisions of the charter or <FONT STYLE="white-space:nowrap">by-laws,</FONT> partnership agreement or operating agreement or similar organizational documents, as applicable, of the Company or any subsidiary
(ii)&nbsp;will not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the
Company or of its subsidiaries pursuant to, or require the consent of any other party to, any Existing Instrument, except as could not be expected, individually or in the aggregate, to have a Material Adverse Effect and (iii)&nbsp;will not result in
any violation of any law, administrative regulation or administrative or court decree applicable to the Company or its subsidiaries, except for such violations as would not be expected, individually or in the aggregate, to have a Material Adverse
Effect. No consent, approval, authorization or other order of, or registration or filing with, any court or other governmental or regulatory authority or agency, is required for the Company&#8217;s execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated hereby and by the Registration Statement, the Pricing Disclosure Package and the Prospectus, except such as have been obtained or made or will be made by the Company under the
Securities Act, as have been obtained or will be made by the Company with Nasdaq, and such as may be required under applicable state securities or blue sky laws or FINRA. As used herein, a &#8220;Debt Repayment Triggering Event&#8221; means any
event or condition which gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company or its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>Compliance with Laws.</I> The
Company and its subsidiaries have been and are in compliance with all applicable laws, rules and regulations, except where failure to be so in compliance could not be expected, individually or in the aggregate, to have a Material Adverse Effect.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <I>No Material Actions or Proceedings</I>. There is no action, suit, proceeding, inquiry or investigation brought by or before any
governmental entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or its subsidiaries, which if determined adversely to the Company or its subsidiaries would reasonably be expected, individually or in
the aggregate, to have a Material Adverse Effect or materially and adversely affect the consummation of the transactions contemplated by this Agreement or the performance by the Company of its obligations hereunder; and the aggregate of all pending
legal or governmental proceedings to which the Company or any such subsidiary is a party or of which any of their respective properties or assets is the subject, including ordinary routine litigation incidental to the business, if determined
adversely to the Company, would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. No material labor dispute with the employees of the Company or its subsidiaries exists or, to the knowledge of the
Company, is threatened or imminent. To the knowledge of the Company, no material labor dispute with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists, or is threatened or imminent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Intellectual Property</I>. (i)&nbsp;The Company and its subsidiaries own or have the right to use all patents, patent rights, statutory
invention rights, community designs, invention disclosures, rights in utility models and industrial designs, inventions, registered and unregistered copyrights (including copyrights in software), intellectual property rights in technology and
software, data, knowhow (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, business names, trade names, logos, slogans, trade dress, design
rights, Internet domain names, social media accounts, any other designations of source or origin, and any applications (including provisional applications), registrations, or renewals for any of the foregoing, rights to publicity and privacy and/or
other intellectual property (collectively, &#8220;Intellectual Property&#8221;) used in or necessary for the conduct of their respective businesses; (ii)&nbsp;the Company&#8217;s and its subsidiaries&#8217; conduct of their respective businesses
does not infringe, misappropriate or otherwise violate, and has not </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
infringed, misappropriated or otherwise violated, any Intellectual Property of any person; (iii)&nbsp;the Company and its subsidiaries have not received any written notice of, or are otherwise
aware of, any claim relating to Intellectual Property, including any claim alleging any infringement, misappropriation or other violation of, or conflict regarding, any Intellectual Property of a third party, and the Company and its subsidiaries are
unaware of any fact which would form a reasonable basis for any such claim; and (iv)&nbsp;to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries is not being and has not been infringed, misappropriated or
otherwise violated by any person and there is no pending or threatened action, suit, proceeding or claim by the Company or any of its subsidiaries against a third party regarding the foregoing. (I)&nbsp;The Company and its subsidiaries have complied
in all material respects with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or its subsidiaries, (II)&nbsp;neither the Company nor any of its subsidiaries has received any written notice
alleging any such noncompliance, and (III)&nbsp;all such agreements are in full force and effect. All Intellectual Property owned by or exclusively licensed to the Company (such Intellectual Property, the &#8220;Company Intellectual Property&#8221;)
is valid, subsisting and enforceable and there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by any third party challenging the validity, ownership, registrability, scope or enforceability of any
Company Intellectual Property and the Company and its subsidiaries are unaware of any facts or circumstances which would form a reasonable basis for any such claim. All Company Intellectual Property has been duly maintained and is in full force and
effect, and all actions or fees necessary to prosecute or maintain the Company Intellectual Property have been timely taken, met or paid and there are no material defects in any of the Company Intellectual Property. Each person who is or was an
employee or contractor of the Company or any of its subsidiaries and who is, was or, in the case of current employees and contractors, is reasonably expected to be involved in the creation or development of any Intellectual Property for or on behalf
of the Company has executed a valid, written agreement containing an effective, present and valid assignment to the Company or any of its subsidiaries of such person&#8217;s rights in and to such Intellectual Property. The Company is not aware of
any violation by any current or former employee of the Company or any of its subsidiaries of any term of any agreement or covenant to or with a former employer of such employee where the basis of such violation relates to such employee&#8217;s
employment with the Company or any of its subsidiaries or actions undertaken by the employee while employed with the Company or any of its subsidiaries. The Company has taken all reasonable steps necessary to maintain the confidentiality of the
trade secrets and other confidential Intellectual Property used in connection with the business of the Company and its subsidiaries, and the confidentiality of such trade secrets and confidential Intellectual Property has not been compromised in
such a matter would deprive the Company&#8217;s trade secrets from the protections afforded to trade secrets under the applicable law, or which would preclude the Company from enforcing confidentiality obligations against persons who have agreed, or
otherwise have a duty to, maintain the confidentiality of such material confidential Intellectual Property. No Intellectual Property has been obtained or is being used by the Company or its subsidiaries in violation of any material contractual
obligations binding on the Company or its subsidiaries in violation of any contractual rights of any person. No university, military, educational institution, research center, governmental entity or other organization has funded, sponsored or
contributed to research and development conducted in connection with the business of the Company or any of its subsidiaries that (1)&nbsp;has any claim of right to, ownership of or other lien on any Intellectual Property Rights or (2)&nbsp;would
affect the proprietary nature of any Company Intellectual Property or restrict the ability of the Company or any of its subsidiaries to enforce, license or exclude others from using any Company Intellectual Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <I>Title to Properties</I>. The Company and its subsidiaries have good and marketable title in fee simple to all real property owned by
them and good and marketable title in all personal property owned by them that is material to the business of the Company and its subsidiaries, in each case free and clear of any lien, charge, pledge, security interest, encumbrance, right of first
refusal, preemptive right or other restriction (&#8220;Liens&#8221;), except for (i)&nbsp;Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the
Company and its subsidiaries and (ii)&nbsp;Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to
penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>Taxes</I>. The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns
required to be paid or filed through the date hereof; and except as otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus, there is no tax deficiency that has been, or would reasonably be
expected to be, asserted against the Company or any of its subsidiaries or any of their respective properties or assets. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Insurance</I>. The Company and its subsidiaries have insurance covering their
respective properties, operations, personnel and businesses, including business interruption insurance, which insurance is in amounts and insures against such losses and risks as are adequate to protect the Company and its subsidiaries and their
respective businesses; and neither the Company nor any of its subsidiaries has (i)&nbsp;received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made in order to
continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) [Reserved.] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)
<I>Compliance with Environmental Laws</I>. (i)&nbsp;The Company and its subsidiaries (x)&nbsp;are in compliance with all, and have not violated any, applicable federal, state, local and foreign laws (including common law), rules, regulations,
requirements, decisions, judgments, decrees, orders and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances or wastes, pollutants
or contaminants (collectively, &#8220;Environmental Laws&#8221;); (y) have received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals required of them under any
Environmental Laws to conduct their respective businesses; and (z)&nbsp;have not received notice of any actual or potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for
the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and have no knowledge of any event or condition that would reasonably be expected to result in any such notice;
(ii)&nbsp;there are no costs or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i)&nbsp;and (ii) above, for any such matter as would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect; and (iii)&nbsp;except as described in each of the Pricing Disclosure Package and the Prospectus, (x)&nbsp;there is no proceeding that is pending, or that is known to be
contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental entity is also a party, other than such proceeding regarding which it is reasonably believed no monetary sanctions of $100,000 or more
will be imposed, (y)&nbsp;the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws, or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or
wastes, pollutants or contaminants, that would reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company and its subsidiaries, and (z)&nbsp;none of the Company or its subsidiaries
anticipates material capital expenditures relating to any Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>No Rated Debt or Preferred Securities.</I> There are
no debt or preferred securities issued, or guaranteed, by the Company or its subsidiaries that are rated by a &#8220;nationally recognized statistical rating organization,&#8221; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>ERISA Compliance</I>. The Company and its subsidiaries and any &#8220;employee benefit plan&#8221; (as defined under the Employee
Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &#8220;ERISA&#8221;)) established or maintained by the Company, its subsidiaries or their &#8220;ERISA Affiliates&#8221;
(as defined below) are in compliance in all material respects with ERISA. &#8220;ERISA Affiliate&#8221; means, with respect to the Company or its subsidiaries, any member of any group of organizations described in Sections 414(b), (c), (m) or
(o)&nbsp;of the Internal Revenue Code of 1986, as amended, and the regulations and published interpretations thereunder (the &#8220;Code&#8221;) of which the Company or its subsidiaries is a member. No &#8220;reportable event&#8221; (as defined
under ERISA), for which notice has not been waived, has occurred or is reasonably expected to occur with respect to any &#8220;employee benefit plan&#8221; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates.
No &#8220;employee benefit plan&#8221; established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates, if such &#8220;employee benefit plan&#8221; were terminated, would have any &#8220;amount of unfunded benefit
liabilities&#8221; (as defined under ERISA). Neither the Company, its subsidiaries nor any of their ERISA Affiliates has incurred or reasonably expects to incur any liability under (i)&nbsp;Title IV of ERISA with respect to termination of, or
withdrawal from, any &#8220;employee benefit plan&#8221; or (ii)&nbsp;Sections 412, 4971, 4975 or 4980B of the Code. Each employee benefit plan established or maintained by the Company, its subsidiaries or any of their ERISA Affiliates that is
intended to be qualified under Section&nbsp;401(a) of the Code is so qualified and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause the loss of such qualification. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>Company Not an &#8220;Investment Company.&#8221;</I> The Company is not, and will
not be, either after receipt of payment for the Shares or after the application of the proceeds therefrom as described under &#8220;Use of Proceeds&#8221; in the Registration Statement, the Pricing Disclosure Package or the Prospectus, required to
register as an &#8220;investment company&#8221; under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>No Price Stabilization or Manipulation; Compliance with Regulation M</I>. Neither the Company nor its subsidiaries have taken,
directly or indirectly, without giving effect to activities by the Underwriter, any action designed to or that might reasonably be expected to cause or result in stabilization or manipulation of the price of the Shares or of any &#8220;reference
security&#8221; (as defined in Rule 100 of Regulation M under the Exchange Act (&#8220;Regulation M&#8221;)) with respect to the Shares, whether to facilitate the sale or resale of the Shares or otherwise, and has taken no action which would
directly or indirectly violate Regulation M. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>Related-Party Transactions</I>. There are no business relationships or related-party
transactions involving the Company or its subsidiaries or any other person required to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that have not been described as required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>FINRA Matters</I>. All of the information provided to the Underwriter or to counsel for the Underwriter by the Company, its counsel,
its officers and directors and, to the Company&#8217;s knowledge, the holders of any securities (debt or equity) or options to acquire any securities of the Company in connection with the offering of the Shares is true, complete, correct and
compliant with FINRA&#8217;s rules and any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rules or NASD Conduct Rules is true, complete and correct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) <I>Parties to <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements</I>. The Company has furnished to the Underwriter a letter
agreement in the form attached hereto as Annex D (the <FONT STYLE="white-space:nowrap">&#8220;Lock-up</FONT> Agreement&#8221;) from each executive officer and director of the Company. If any additional persons shall become directors or officers of
the Company prior to the end of the <FONT STYLE="white-space:nowrap">90-day</FONT> restricted period referred to in Section&nbsp;4(h) hereof, the Company shall cause each such person, prior to or contemporaneously with their appointment or election
as a director or officer of the Company, to execute and deliver to the Underwriter a <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) <I>Statistical and Market-Related Data</I>. All statistical, demographic and market-related data included in the Registration Statement,
the Pricing Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate. To the extent required, the Company has obtained the written consent to the use
of such data from such sources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) <I>No Unlawful Contributions or Other Payments</I>. Neither the Company nor its subsidiaries nor, to
the best knowledge of the Company, any employee or agent of the Company or its subsidiaries, has made any contribution or other payment to any official of, or candidate for, any federal, state or foreign office in violation of any applicable law or
of the character required to be disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
<I>Foreign Corrupt Practices Act</I>. Neither the Company nor its subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee, controlled affiliate or other person acting on behalf of the Company or its subsidiaries
have, in the course of its actions for, or on behalf of, the Company or its subsidiaries (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)&nbsp;made
any direct or indirect unlawful payment to any domestic government official, &#8220;foreign official&#8221; (as defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder, collectively, the
&#8220;FCPA&#8221;) or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of the FCPA or any applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> anti-bribery statute or regulation; or (iv)&nbsp;made any
unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any domestic government official, such foreign official or employee; and the Company and its subsidiaries and, to the knowledge of the Company, the
Company&#8217;s other controlled affiliates have conducted their respective businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) <I>Money Laundering Laws</I>. The operations of the Company and its subsidiaries are,
and have been conducted at all times, in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable
jurisdictions, the rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;Money Laundering Laws&#8221;) and no
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company,
threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) <I>OFAC</I>. Neither the Company nor its subsidiaries nor, to the knowledge of the Company, any director, officer,
agent, employee, controlled affiliate or person acting on behalf of the Company or its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;OFAC&#8221;)
of the Treasury or the U.S. Department of State and including, without limitation, the designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;, the United Nations Security Council, the European Union, His
Majesty&#8217;s Treasury or other relevant sanctions authority (&#8220;Sanctions&#8221;), nor is the Company located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Cuba,
Iran, North Korea, Syria, the Crimea Region and the <FONT STYLE="white-space:nowrap">non-government</FONT> controlled areas of the Zaporizhzhia and Kherson Regions of Ukraine, the <FONT STYLE="white-space:nowrap">so-called</FONT> Donetsk
People&#8217;s Republic, the <FONT STYLE="white-space:nowrap">so-called</FONT> Luhansk People&#8217;s Republic and any other Covered Region of Ukraine identified pursuant to Executive Order 14065 (each, a &#8220;Sanctioned Country&#8221;); and the
Company will not directly or indirectly use the proceeds of this offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other person or entity, (i)&nbsp;for the purpose of financing
the activities of or business with any person, or in any country or territory, that currently is the subject of Sanctions, (ii)&nbsp;to fund or facilitate any activities of or business in any Sanctioned Country or (iii)&nbsp;in any other manner that
will result in a violation by any person (including any person participating in the transaction whether as underwriter, advisor, investor or otherwise) of applicable Sanctions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) <I>Brokers</I>. Except pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the Company
any brokerage or finder&#8217;s fee or other fee or commission as a result of any transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm)
<I>Forward-Looking Statements.</I> Each financial or operational projection or other &#8220;forward-looking statement&#8221; (as defined by Section&nbsp;27A of the Securities Act or Section&nbsp;21E of the Exchange Act) contained in the Registration
Statement, the Pricing Disclosure Package or the Prospectus (i)&nbsp;was so included by the Company in good faith and with reasonable basis after due consideration by the Company of the underlying assumptions, estimates and other applicable facts
and circumstances and (ii)&nbsp;is accompanied by meaningful cautionary statements identifying those factors that could cause actual results to differ materially from those in such forward-looking statement. No such statement was made with the
knowledge of an executive officer or director of the Company that it was false or misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) <I>Compliance with Data Privacy
Laws</I>. To the Company&#8217;s knowledge, the Company and its subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and security laws and regulations (collectively, the
&#8220;Privacy Laws&#8221;). The Company and its subsidiaries take commercially reasonable steps reasonably designed to ensure compliance in all material respects with their policies and procedures relating to data privacy and security and the
collection, storage, use, disclosure, handling, and analysis of Personal Data (as defined below) (the &#8220;Policies&#8221;). The Company and its subsidiaries have at all times made all disclosures to users or customers required by the Privacy
Laws, and none of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any Privacy Laws in any material respect. The Company further certifies that neither it nor any
subsidiaries: (i)&nbsp;have received written notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, (ii)&nbsp;is currently conducting or paying for, in whole or in part, any
investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii)&nbsp;is a party to any order, decree, or agreement from or with a governmental or regulatory authority or agency that imposes any obligation or liability
under any Privacy Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) <I>Cybersecurity; Data Protection</I>. To the Company&#8217;s knowledge, the Company and its
subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and databases (collectively, &#8220;IT Systems&#8221;) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to
maintain and protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including &#8220;Personal Data,&#8221; used in connection with their businesses.
&#8220;Personal Data&#8221; means (i)&nbsp;a natural person&#8217;s name, street address, telephone number, <FONT STYLE="white-space:nowrap">e-mail</FONT> address, photograph, social security number or tax identification number, driver&#8217;s
license number, passport number, credit card number, bank information, or customer or account number; (ii)&nbsp;any information which would qualify as &#8220;personally identifying information&#8221; under the Federal Trade Commission Act, as
amended; (iii) &#8220;personal data&#8221; as defined by GDPR; (iv)&nbsp;any information which would qualify as &#8220;protected health information&#8221; under HIPAA; and (v)&nbsp;any other piece of information that allows the identification of
such natural person, or his or her family, or permits the collection or analysis of any data related to an identified person&#8217;s health or sexual orientation. There have been no breaches, violations, outages or unauthorized uses of or accesses
to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or investigations relating to the same. The Company and its subsidiaries are
presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the
privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) <I>No Rights to Purchase Preferred Stock.</I> The issuance and sale of the Shares as contemplated hereby will not cause any holder of any
shares of capital stock, securities convertible into or exchangeable or exercisable for capital stock or options, warrants or other rights to purchase capital stock or any other securities of the Company to have any right to acquire any shares of
preferred stock of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) <I>Dividend Restrictions</I>. Except as otherwise disclosed in the Registration Statement, the
Pricing Disclosure Package and the Prospectus, no subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying dividends to the Company, or from making any other distribution with respect to such subsidiary&#8217;s
equity securities or from repaying to the Company or any other subsidiary of the Company any amounts that may from time to time become due under any loans or advances to such subsidiary from the Company or from transferring any property or assets to
the Company or to any other subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) <I>Sarbanes-Oxley.</I> The Company is, and after giving effect to the offering and sale of
Shares will be, in compliance in all material respects with all applicable effective provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss) <I>Margin Rules</I>. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as
described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt) <I>Status under the Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the
earliest time thereafter that the Company or any offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under the Securities Act) of the Shares and at the date hereof, the Company was not and is not or will not be (as
applicable) an &#8220;ineligible issuer,&#8221; in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements of the Company</U>. The Company covenants and agrees with the Underwriter that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings.</I> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b)
and Rule 430A, 430B or 430C under the Securities Act, and will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the Securities Act; and the Company will file within the time periods required by the Commission all
reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long as the
delivery of a prospectus is required in connection with the offering or sale of the Shares; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the Underwriter in
New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of this Agreement in such quantities as the Underwriter may reasonably request. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of Copies.</I> The Company will deliver, without charge, promptly upon
request (i)&nbsp;to the Underwriter, two signed copies of the Registration Statement as originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith and documents incorporated by reference therein;
and (ii)&nbsp;to the Underwriter (A)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B)&nbsp;during the Prospectus Delivery Period (as defined below), as many copies of the
Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein and each Issuer Free Writing Prospectus) as the Underwriter may reasonably request. As used herein, the term &#8220;Prospectus Delivery
Period&#8221; means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriter a prospectus relating to the Shares is required by law to be delivered (or required to be delivered
but for Rule 172 under the Securities Act) in connection with sales of the Shares by any Underwriter or dealer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Amendments or
Supplements, Issuer Free Writing Prospectuses.</I> During the Prospectus Delivery Period, before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or
supplement to the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company will furnish to the Underwriter and counsel for the Underwriter a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement
for review and will not make, prepare, use, authorize, approve, refer to or file any such, Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Underwriter reasonably object. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the Underwriter.</I> The Company will advise the Underwriter promptly, and confirm such advice in writing (which confirmation
may be delivered by electronic mail), (i) when any amendment to the Registration Statement has been filed or becomes effective; (ii)&nbsp;when any supplement to the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or
any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or any amendment to the Prospectus has been filed or distributed; (iii)&nbsp;of any request by the Commission for any
amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information
including, but not limited to, any request for information concerning any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication; (iv)&nbsp;of the issuance by the Commission or any other
governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package, the Prospectus or any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or the initiation or, to the Company&#8217;s knowledge, threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the
Securities Act; (v)&nbsp;of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing Disclosure Package, any Issuer Free Writing Prospectus or any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication as then amended or supplemented would include any untrue statement of a material fact or omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, any such Issuer Free Writing Prospectus or any Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication is delivered to a purchaser, not misleading; and (vi)&nbsp;of the receipt by the Company of any notice with respect to any suspension of
the qualification of the Shares for offer and sale in any jurisdiction or the initiation or, to the Company&#8217;s knowledge, threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the
issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package or the Prospectus or any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication or suspending any such qualification of the Shares and, if any such order is issued, will use its reasonable best efforts to obtain as soon as
possible the withdrawal thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Ongoing Compliance.</I> (1)&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event or
development shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with applicable law, the Company will promptly notify
the Underwriter thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to the Prospectus (or
any document to be filed with the Commission and incorporated by reference therein) as may be </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
necessary so that the statements in the Prospectus as so amended or supplemented (or any document to be filed with the Commission and incorporated by reference therein) will not, in the light of
the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with applicable law and (2)&nbsp;if at any time prior to the Closing Date or any Additional Closing Date (i)&nbsp;any
event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Pricing Disclosure Package to comply
with applicable law, the Company will promptly notify the Underwriter thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriter and to such dealers as the
Underwriter may designate such amendments or supplements to the Pricing Disclosure Package (or any document to be filed with the Commission and incorporated by reference therein) as may be necessary so that the statements in the Pricing Disclosure
Package as so amended or supplemented will not, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure Package will comply with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Blue Sky Compliance.</I> The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such
jurisdictions as the Underwriter shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Shares; <U>provided</U> that the Company shall not be required to (i)&nbsp;qualify as a foreign
corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process in any such jurisdiction or (iii)&nbsp;subject itself
to taxation in any such jurisdiction if it is not otherwise so subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Earnings Statement. </I>The Company will make generally
available to its security holders and the Underwriter as soon as practicable an earnings statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of
at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#8220;effective date&#8221; (as defined in Rule 158) of the Registration Statement; provided that the Company will be deemed to have furnished such
statements to its security holders and the Underwriter to the extent they are filed on EDGAR or any successor system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)<I> Clear
Market.</I> For a period of 90 days after the date of the Prospectus, the Company will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or
warrant to purchase, hedge, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement under the Securities Act relating to, any shares of Stock or any securities
convertible into or exercisable or exchangeable for Stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any hedging, swap or other agreement that transfers, in whole or in part, any of the economic
consequences of ownership of the Stock or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written
consent of the Underwriter, other than the Shares to be sold hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions described above do not apply to (i) the issuance
of shares of Stock or securities convertible into or exercisable for shares of Stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the vesting or
settlement of restricted stock, restricted stock units or performance units (including net settlement), in each case outstanding on the date of this Agreement and described in the Prospectus; (ii) grants of stock options, stock awards, restricted
stock, restricted stock units, performance units, or other equity awards and the issuance of shares of Stock or securities convertible into or exercisable or exchangeable for shares of Stock (whether upon the exercise of stock options or otherwise)
to the Company&#8217;s employees, officers, directors, advisors, or consultants pursuant to the terms of an inducement plan or an equity compensation plan, or employee stock purchase plan in effect as of the Closing Date and described in the
Prospectus; (iii) the offer, negotiation, and entrance into a binding agreement for the issuance of up to 10% of the outstanding shares of Stock, or securities convertible into, exercisable for, or which are otherwise exchangeable for, Stock,
immediately following the Closing Date, in acquisitions, strategic transactions of assets or acquisition of equity of another entity or in connection with a transaction with an unaffiliated third party that includes a bona fide commercial
relationship (including joint ventures, marketing or distribution arrangements, collaboration agreements, intellectual property license agreements, or lending agreements or arrangements), provided that such recipients enter into a <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement with the Underwriter; (iv) the filing of any registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> relating to </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities granted or to be granted pursuant to any plan in effect on the date of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition or similar
strategic transaction; (v)&nbsp;up to an aggregate of 1,000,000 shares of Stock pursuant to (a)&nbsp;sales under an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">at-the-market</FONT></FONT> sales arrangement and/or (b)&nbsp;in
exchange for outstanding preferred securities of the Company, or (vi)&nbsp;the issuance of shares of Stock pursuant to, and in accordance with, the terms of the Stock Purchase Agreement, dated as of February&nbsp;12, 2026, by and among the Company
and the Sellers (as defined therein). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Use of Proceeds.</I> The Company will apply the net proceeds from the sale of the Shares as
described in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus under the heading &#8220;Use of Proceeds.&#8221; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No Stabilization.</I> Neither the Company nor its subsidiaries will take, and the Company will ensure that its controlled affiliates
will not take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock and will not take any action prohibited by Regulation M under the
Exchange Act in connection with the distribution of the Shares contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) [Reserved.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Reports.</I> For a period of two years from the date of this Agreement, so long as the Shares are outstanding, the Company will furnish
to the Underwriter, as soon as commercially reasonable after the date on which they are available, copies of all reports or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial
statements furnished to or filed with the Commission or any national securities exchange or automatic quotation system; <U>provided</U> the Company will be deemed to have furnished such reports and financial statements to the Underwriter to the
extent they are filed on EDGAR or any successor system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Record Retention</I>. The Company will, pursuant to reasonable procedures
developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Certain Agreements of the Underwriter</U>. The Underwriter hereby represents and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and will not use, authorize use of, refer to or participate in the planning for use of, any &#8220;free writing
prospectus,&#8221; as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release
issued by the Company) other than (i) a free writing prospectus that contains no &#8220;issuer information&#8221; (as defined in Rule 433(h)(2) under the Securities Act) that was not included (including through incorporation by reference) in the
Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show approved in advance
by the Company), or (iii) any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an &#8220;Underwriter Free Writing
Prospectus&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It has not and will not, without the prior written consent of the Company, use any free writing prospectus that
contains the final terms of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <I>provided</I> that Underwriter may use a term sheet substantially in the form of Annex C hereto without
the consent of the Company; <I>provided further</I> that any Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or substantially concurrently with, the first use of such term
sheet. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will
promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriter&#8217;s Obligations.</U> The obligation of the Underwriter
to purchase the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to
the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order.</I> No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose, or pursuant to Section 8A under the Securities Act shall be pending before or, to the knowledge of the Company, threatened by the Commission; the Prospectus and each
Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus), to the extent required by Rule 433 under the Securities Act and in accordance with Section
4(a) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Underwriter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Representations and Warranties.</I> The representations and warranties of the Company contained herein shall be true and correct on the
date hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of
the Closing Date or the Additional Closing Date, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Material Adverse Change.</I> No event or condition of a
type described in Section 3(h) hereof shall have occurred or shall exist, which event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or
supplement thereto) and the effect of which in the judgment of the Underwriter makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Underwritten Shares on the Closing Date or the Option Shares on the Additional
Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Officer&#8217;s Certificate.</I> The Underwriter shall have received on and as of the Closing Date or the Additional Closing Date, as
the case may be, a certificate of the chief financial officer or chief accounting officer of the Company and one additional senior executive officer of the Company who is satisfactory to the Underwriter (i) confirming that such officers have
carefully reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officers, the representations set forth in Sections 3(a) and 3(b) hereof are true and correct, (ii) confirming that the
other representations and warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the
Closing Date or the Additional Closing Date, as the case may be, and (iii) to the effect set forth in paragraphs (a), (b) and (c) above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Comfort Letters.</I> (i) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be,
EisnerAmper LLP shall have furnished to the Underwriter, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriter, in form and substance reasonably satisfactory to the Underwriter,
containing statements and information of the type customarily included in accountants&#8217; &#8220;comfort letters&#8221; to underwriters with respect to the financial statements and certain financial information contained or incorporated by
reference in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a <FONT
STYLE="white-space:nowrap">&#8220;cut-off&#8221;</FONT> date no more than three business days prior to such Closing Date or such Additional Closing Date, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Opinion and Negative Assurance Letter of Counsel for the Company.</I> Kelley Drye&nbsp;&amp; Warren LLP, counsel for the Company, shall
have furnished to the Underwriter, at the request of the Company, its written opinion and negative assurance letter, dated the Closing Date or the Additional Closing Date, as the case may be, and addressed to the Underwriter, in form and substance
reasonably satisfactory to the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Opinion of Counsel for the Underwriter.</I> The Underwriter shall have received on and
as of the Closing Date or the Additional Closing Date, as the case may be, an opinion that shall contain a negative assurance statement, addressed to the Underwriter, of Faegre Drinker Biddle&nbsp;&amp; Reath LLP, counsel for the Underwriter, with
respect to such matters as the Underwriter may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon such matters. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>No Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no
statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the
issuance or sale of the Shares by the Company; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date or the Additional Closing Date by Company, as the case may be, prevent the
issuance or sale of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Good Standing</I>. The Underwriter shall have received on and as of the Closing Date or the
Additional Closing Date, as the case may be, satisfactory evidence of the good standing of the Company and its subsidiaries in their jurisdiction of organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</I>. The <FONT STYLE="white-space:nowrap">&#8220;lock-up&#8221;</FONT>
agreements, each substantially in the form of Annex D hereto, executed by certain officers and directors of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities, delivered to the Underwriter on
or before the date hereof, shall be in full force and effect on the Closing Date or the Additional Closing Date, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)
<I>CFO Certificate</I>. On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Underwriter a certificate, dated the respective dates of delivery thereof and
addressed to the Underwriter, of its chief financial officer with respect to certain financial data contained in the Pricing Disclosure Package and the Prospectus, providing &#8220;management comfort&#8221; with respect to such information, in form
and substance reasonably satisfactory to the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Exchange Listing</I>. The Company shall have submitted a Listing of
Additional Shares notification to Nasdaq with respect to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Additional Documents</I>. On or prior to the Closing Date or
the Additional Closing Date, as the case may be, the Company shall have furnished to the Underwriter such further certificates and documents as the Underwriter may reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the
provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Indemnification and
Contribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of the Underwriter.</I> The Company agrees to indemnify and hold harmless the Underwriter, its
affiliates, directors and officers and each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities
(including, without limitation, reasonable and documented legal fees and other expenses reasonably incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred) that arise out of, or are
based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in
order to make the statements therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free
Writing Prospectus, any &#8220;issuer information&#8221; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication, any road show as defined in Rule 433(h) under the Securities Act (a &#8220;road show&#8221;) or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or
alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities
arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information relating to the Underwriter furnished to the Company in writing by the Underwriter
expressly for use therein, it being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such in paragraph (b) below. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of the Company.</I> The Underwriter agrees to indemnify and hold
harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as
the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages or liabilities (including, without limitation, reasonable and documented legal fees and other expenses incurred in connection with any suit, action,
or proceeding or any claim asserted, as such fees and expenses are incurred) that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any information
relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing
Prospectus, any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, any road show or any Pricing Disclosure Package (including any Pricing Disclosure Package that has subsequently
been amended), it being understood and agreed upon that the only such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of the Underwriter: the concession and reallowance figures
appearing in the second paragraph under the caption &#8220;Underwriting&#8221; and the seventh, eighth, ninth, and tenth paragraphs under the caption &#8220;Underwriting&#8221; relating to price stabilization, short positions and penalty bids. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notice and Procedures.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand
shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this Section 7, such person (the &#8220;Indemnified Person&#8221;) shall promptly notify the person against
whom such indemnification may be sought (the &#8220;Indemnifying Person&#8221;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under the preceding paragraphs of
this Section 7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the Indemnifying Person shall not
relieve it from any liability that it may have to an Indemnified Person otherwise than under the preceding paragraphs of this Section 7. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the
Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the
Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate in such proceeding and shall pay the reasonably incurred and documented fees and expenses in such proceeding and shall
pay the reasonably incurred and documented fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such
counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or
(iv) the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential
differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate
firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any
control persons of the Underwriter shall be designated in writing by the Underwriter and any such separate firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be
designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the
Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that
an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such
settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such
settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and
indemnification could have been sought hereunder by such Indemnified Person, unless </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are
the subject matter of such proceeding and (y) does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Contribution.</I> If the indemnification provided for in paragraphs (a) or (b) above is unavailable to an Indemnified Person or
insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable
by such Indemnified Person as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriter on the other, from the
offering of the Shares or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the
Company, on the one hand, and the Underwriter on the other, in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits
received by the Company, on the one hand, and the Underwriter on the other, shall be deemed to be in the same respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Shares and the total
underwriting discounts and commissions received by the Underwriter in connection therewith, in each case as set forth in the table on the cover of the Prospectus, bear to the aggregate offering price of the Shares. The relative fault of the Company,
on the one hand, and the Underwriter on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to
information supplied by the Company or by the Underwriter and the parties&#8217; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Limitation on Liability.</I> The Company and the Underwriter agree that it would not be just and equitable if contribution pursuant to
paragraph (d) above were determined by <U>pro rata</U> allocation or by any other method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person
as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any documented legal or other expenses reasonably incurred by such Indemnified
Person in connection with any such action or claim. Notwithstanding the provisions of paragraphs (d) and (e), in no event shall the Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts
and commissions received by the Underwriter with respect to the offering of the Shares exceeds the amount of any damages that the Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or
alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies.</I> The remedies provided for in this Section 7 paragraphs (a) through
(e) are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Effectiveness of Agreement</U>. This Agreement shall become effective as of the date first written above upon the execution and delivery
hereof by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Termination</U>. This Agreement may be terminated in the absolute discretion of the Underwriter, by
notice to the Company, if after the execution and delivery of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date (i) trading generally shall have been suspended or materially
limited on or by either of the New York Stock Exchange or Nasdaq; (ii) trading of any securities issued by the Company shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv) there
shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Underwriter, is material and adverse and makes it
impracticable or inadvisable to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on the terms and in the manner contemplated by this Agreement, the Pricing Disclosure
Package and the Prospectus. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Payment of Expenses</U><I>.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Whether or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or
cause to be paid the following: (i)&nbsp;the fees, disbursements and expenses of the Company&#8217;s counsel and accountants in connection with the registration of the Shares under the Act and all other expenses in connection with the preparation,
printing, reproduction and filing of the Registration Statement, the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits, amendments and supplements thereto) and the
distribution thereof; (ii)&nbsp;the cost of printing or producing this Agreement, the Blue Sky survey, closing documents (including any compilations thereof) and any other documents in connection with the offering, purchase, sale and delivery of the
Shares; (iii)&nbsp;all expenses in connection with the qualification of the Shares for offering and sale under state securities laws; (iv)&nbsp;all fees and expenses in connection with listing the Shares on Nasdaq; (v)&nbsp;the filing fees incident
to and in connection with, any required review by FINRA of the terms of the sale of the Shares; (vi)&nbsp;the cost of preparing stock certificates, if applicable; (vii)&nbsp;the cost and charges of any transfer agent, or registrar; (viii)&nbsp;the
costs and expenses of the Company relating to investor presentations on any &#8220;road show&#8221; undertaken in connection with the marketing of the Shares, including without limitation, expenses associated with the production of road show slides
and graphics, fees; and (ix)&nbsp;all other costs and expenses incident to the performance of its obligations hereunder which are not otherwise specifically provided for in this Section&nbsp;10. It is understood, however, that, except as provided in
this Section&nbsp;10 and Section&nbsp;7 hereof, the Underwriter will pay all of its own costs and expenses; provided, however, that the Company will reimburse the Underwriter for all
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (including fees and expenses of its counsel) reasonably incurred and documented by it in connection with its engagement hereunder in an aggregate
amount that shall not exceed $75,000 without the prior written approval of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i) this Agreement is terminated pursuant
to Section 9, (ii) the Company for any reason fails to tender the Shares for delivery to the Underwriter or (iii) the Underwriter declines to purchase the Shares for any reason permitted under this Agreement, the Company agrees to reimburse the
Underwriter for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the fees and expenses of its counsel) reasonably incurred by the Underwriter in connection with this
Agreement and the offering contemplated hereby. For the avoidance of doubt, it is understood that the Company shall not pay or reimburse any costs, fees or expenses incurred by any Underwriter that defaults on its obligation to purchase the Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto
and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of the Underwriter referred to in Section 7 hereof. Nothing in this Agreement is intended or shall be construed to give
any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and
the Underwriter contained in this Agreement or made by or on behalf of the Company or the Underwriter pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the Shares and shall remain
in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriter or the directors, officers, controlling persons or affiliates referred to in Section 7 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Certain Defined Terms</U>. For purposes of this Agreement, (a) except where otherwise expressly provided, the term
&#8220;affiliate&#8221; has the meaning set forth in Rule 405 under the Securities Act; (b) the term &#8220;business day&#8221; means any day other than a day on which banks are permitted or required to be closed in New York City and (c) the term
&#8220;subsidiary&#8221; has the meaning set forth in Rule&nbsp;405 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Compliance with USA Patriot Act</U>.
In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October 26, 2001)), the Underwriter is required to obtain, verify and record information that identifies
its clients, including the Company, which information may include the name and address of its clients, as well as other information that will allow the Underwriter to properly identify its clients. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Notices.</I> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed
or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriter shall be given to the Underwriter c/o The Benchmark Company, LLC, 150 East 58<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street, 17<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> Floor, New York, New York 10155, with a copy (which shall not constitute notice) to Faegre Drinker Biddle&nbsp;&amp; Reath LLP, 200 Wells Fargo Center 90 S. Seventh Street, Minneapolis, Minnesota
55402, Attention: Jonathan Zimmerman. Notices to the Company shall be given to it at Cineverse Corp. 224 W. 35<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street, New York, New York 10001, with a copy (which shall not constitute notice)
to Kelley Drye&nbsp;&amp; Warren LLP, 300 Atlantic Street, Suite 700, Stamford, Connecticut 06901, Attention: Carol W. Sherman. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<I>Governing Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed in accordance with the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Submission to Jurisdiction</I>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts
in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. The Company waives any objection which it may now or hereafter have to the laying of
venue of any such suit or proceeding in such courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding upon the Company and may be enforced in any court to the
jurisdiction of which Company is subject by a suit upon such judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Waiver of Jury Trial.</I> Each of the parties hereto hereby
waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Recognition of the U.S. Special Resolution Regimes</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution
Regime, the transfer from the Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this
Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of the Underwriter becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section 15(e): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;BHC Act Affiliate&#8221; has the meaning assigned to the term &#8220;affiliate&#8221; in, and shall be interpreted in
accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;Covered Entity&#8221; means any of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&#167; 382.2(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#8220;Default Right&#8221; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12
C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#8220;U.S. Special Resolution Regime&#8221; means each of (i) the Federal Deposit
Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Counterparts.</I> This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of
telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. This Agreement may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com or www.echosign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Amendments or Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure
therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Headings.</I> The
headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CINEVERSE CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher J. McGurk</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Christopher J. McGurk</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR></TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted: As of the date first written above</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">THE BENCHMARK COMPANY, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John J. Borer III</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: John J. Borer III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Head of Investment Banking</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature Page to
Underwriting Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">SCHEDULE I </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Shares</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Benchmark Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule I to
Underwriting Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">SCHEDULE II </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Significant Subsidiaries </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cineverse
Entertainment Corp. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cineverse Entertainment Holdings LLC </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cineverse Home Entertainment LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cineverse OTT Holdings LLC
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cineverse Matchpoint LLC </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule II to
Underwriting Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">ANNEX A </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Pricing Disclosure Package</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Pricing Information Provided Orally by the Underwriter</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Public Offering Price per Share: $1.8803 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Number of Underwritten Shares: 1,500,000 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Number of Option Shares: 225,000 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex A to Underwriting
Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">ANNEX B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B to Underwriting
Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">ANNEX C </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Cineverse Corp. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Pricing Term
Sheet </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex C to Underwriting
Agreement </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">ANNEX D </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>&#8195;&#8195;&#8195;&#8195;</U> , 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Benchmark Company, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">150 East 58<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Street,
17<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10155 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: Cineverse Corp. Public Offering </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that you, as underwriter (the &#8220;Underwriter&#8221;), propose to enter into an underwriting agreement (the
&#8220;Underwriting Agreement&#8221;) with Cineverse Corp., a Delaware corporation (the &#8220;Company&#8221;), providing for the public offering (the &#8220;Public Offering&#8221;) by the Underwriter, of Class&nbsp;A common stock, par value $0.001
per share (the &#8220;Common Stock&#8221;), of the Company, and which may also include the public offering of warrants to purchase Common Stock (together, the &#8220;Securities&#8221;). Capitalized terms used herein and not otherwise defined shall
have the meanings set forth in the Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the Underwriter&#8217;s agreement to purchase and make the
Public Offering of the Securities, and for other good and valuable consideration receipt of which is hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Underwriter, the undersigned will not, and will
not cause any direct or indirect affiliate to, during the period beginning on the date hereof and ending at the close of business 90 days after the date of the final prospectus relating to the Public Offering (the &#8220;Prospectus&#8221;) (such
period, the &#8220;Restricted Period&#8221;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or
dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or such other securities which may be deemed to be
beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant) (collectively with the Common Stock, the <FONT
STYLE="white-space:nowrap">&#8220;Lock-Up</FONT> Securities&#8221;), (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, in cash or otherwise,
(3)&nbsp;make any demand for or exercise any right with respect to the registration of any <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, or (4)&nbsp;publicly disclose the intention to do any of the foregoing. During the Restricted
Period, the undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into,
any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition
or transfer (whether by the undersigned or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, whether any such transaction or
arrangement (or instrument provided for thereunder) would be settled by delivery of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, in cash or otherwise. The undersigned further confirms that the undersigned has furnished the Underwriter
with the details of any transaction the undersigned, or any of the undersigned&#8217;s affiliates, is a party to as of the date hereof, which transaction would have been restricted by this agreement (the &#8220;Letter Agreement&#8221;) if it had
been entered into by the undersigned during the Restricted Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the undersigned may: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) transfer or dispose of the undersigned&#8217;s <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) as a bona fide gift or gifts, or for bona fide estate planning purposes, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) by will or intestacy, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to any (A)&nbsp;immediate family of the undersigned or (B)&nbsp;trust for the direct or indirect benefit of the undersigned or the
immediate family of the undersigned, or if the undersigned is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes of this Letter Agreement, &#8220;immediate family&#8221; shall mean any
relationship by blood, current or former marriage, domestic partnership or adoption, not more remote than first cousin), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) to a
corporation, partnership, limited liability company or other entity of which the undersigned or the immediate family of the undersigned are the legal and beneficial owner of all of the outstanding equity securities or similar interests, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i)&nbsp;through (iv)
above, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) if the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A)&nbsp;to
another corporation, partnership, limited liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned, or to any investment fund or other
entity controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a
successor partnership or fund, or any other funds managed by such partnership), or (B)&nbsp;as part of a distribution to members, partners, shareholders or other equityholders of the undersigned, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or
related court order, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) to the Company from an employee of the Company upon death, disability or termination of employment, in each
case, of such employee, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) as part of a sale of the undersigned&#8217;s <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities
acquired in the Public Offering and any transaction with respect to shares of Common Stock acquired in open market transactions after the completion of the Public Offering, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) in connection with the vesting, settlement, or exercise of restricted stock, restricted stock units or performance units (including, in
each case, by way of &#8220;net&#8221; or &#8220;cashless&#8221; exercise), solely to cover the payment of any necessary tax and remittance payments due as a result of the vesting or settlement of such restricted stock, restricted stock units or
performance units, provided that any such shares of Common Stock received upon such vesting or settlement (other than such shares as are transferredy in connection with such vesting or settlement solely to cover the payment of any necessary tax and
remittance payments due as a result of the vesting or settlement) shall be subject to the terms of this Letter Agreement, and provided further that any such restricted stock, restricted stock units or performance units are held by the undersigned
pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan which is described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of
Directors of the Company and made to all holders of the Company&#8217;s capital stock involving a Change of Control of the Company. For purposes hereof, &#8220;Change of Control&#8221; shall mean the transfer (whether by tender offer, merger,
consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the Underwriter pursuant to the Public Offering), of shares of capital stock if, after such
transfer, such person or group of affiliated persons would hold more than 50% of the outstanding voting securities of the Company (or the surviving entity)); provided that in the event that such tender offer, merger, consolidation or other similar
transaction is not completed, the undersigned&#8217;s <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities shall remain subject to the provisions of this Letter Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>provided</U> that (A)&nbsp;in the case of any transfer or distribution pursuant to
clauses (a)(i), (ii), (iii), (iv), (v) and (vi), such transfer shall not involve a disposition for value, (B)&nbsp;in the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v), (vi) and (vii), each donee, devisee,
transferee or distributee shall execute and deliver to the Underwriter a <FONT STYLE="white-space:nowrap">lock-up</FONT> letter in the form of this Letter Agreement, (C)&nbsp;in the case of any transfer or distribution pursuant to clause (a)(ii),
(iii), (iv), (v), and (vi), no filing by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or other public announcement
reporting a reduction in beneficial ownership of shares of Common Stock shall be required or shall be made voluntarily in connection with such transfer or distribution (other than a filing on a Form 5 made after the expiration of the Restricted
Period referred to above) and (D)&nbsp;in the case of any transfer or distribution pursuant to clauses (a)(i), (vii), (viii), (ix) and (x)&nbsp;it shall be a condition to such transfer that no public filing, report or announcement shall be
voluntarily made and if any filing under Section&nbsp;16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock in connection with such transfer or distribution
shall be legally required during the Restricted Period, such filing, report or announcement shall clearly indicate the nature and conditions of such transfer in the footnotes thereto or by transaction code; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) exercise outstanding options or warrants, or settle restricted stock, restricted stock units, performance units or other equity awards
pursuant to plans described in the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided that any <FONT STYLE="white-space:nowrap">Lock-up</FONT> Securities received upon such exercise, vesting or settlement shall be
subject to the terms of this Letter Agreement; <U>provided</U> that if the undersigned is required to make any filing under Section&nbsp;16(a) of the Exchange Act, or other public filing, report or announcement during the Restricted Period, the
undersigned shall clearly indicate that the filing relates to the circumstances described in this clause by footnotes thereto or transaction code and that the shares of Common Stock received upon the exercise, vesting or settlement, as applicable,
are subject to this Letter Agreement, and no public filing, report or announcement shall be voluntarily made; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) convert outstanding
preferred stock into shares of Common Stock; provided that any such shares of Common Stock received upon such conversion shall be subject to the terms of this Letter Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) establish trading plans pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares
of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities (each such plan, a &#8220;Trading Plan&#8221;); provided that (1)&nbsp;such Trading Plans do not provide for the transfer of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities
during the Restricted Period and (2)&nbsp;no filing by any party under the Exchange Act or other public announcement shall be made voluntarily during the Restricted Period in connection with such trading plan and if any such filing or public
announcement shall be legally required during the Restricted Period, such filing or public announcement shall clearly indicate therein that none of the securities subject to such plan may be transferred, sold or otherwise disposed of pursuant to
such plan until after expiration of the Restricted Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is not a natural person, the undersigned represents and
warrants that no single natural person, entity or &#8220;group&#8221; (within the meaning of Section&nbsp;13(d)(3) of the Exchange Act) other than a natural person, entity or &#8220;group&#8221; (as described above) that has executed a Letter
Agreement in substantially the same form as this Letter Agreement, beneficially owns, directly or indirectly, 50% or more of the common equity interests, or 50% or more of the voting power, in the undersigned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is an officer or director of the Company, (i)&nbsp;the Underwriter agrees that, at least three business days before the
effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, the Underwriter will notify the Company of the impending release or waiver,
and (ii)&nbsp;the Company has agreed in the Underwriting Agreement to announce the impending release or waiver through a major news service at least two business days before the effective date of the release or waiver. Any release or waiver granted
by the Underwriter hereunder to any such officer or director shall only be effective two business days after the publication date of such announcement. The provisions of this paragraph will not apply if (a)&nbsp;the release or waiver is effected
solely to permit a transfer not for consideration or that is to an immediate family member as defined in FINRA Rule 5130(i)(5) and (b)&nbsp;the transferee has agreed in writing to be bound by the same terms described in this Letter Agreement to the
extent and for the duration that such terms remain in effect at the time of the transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All
authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives of the undersigned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and agrees that the Underwriter has not provided any recommendation or investment advice nor has the Underwriter
solicited any action from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted its own legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned
further acknowledges and agrees that, although the Underwriter may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with the Public Offering, the Underwriter is not making a
recommendation to you to enter into this Letter Agreement and nothing set forth in such disclosures is intended to suggest that the Underwriter is making such a recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that, (i)&nbsp;if the Underwriting Agreement does not become effective by February&nbsp;27, 2026, (ii) if the
Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder, (iii)&nbsp;the Company notifies the Underwriter, or
the Underwriter notifies the Company, in writing prior to the execution of the Underwriting Agreement that it does not intend to proceed with the Public Offering, or (iv)&nbsp;prior to payment for the Securities, the Registration Statement is
withdrawn prior to the execution of the Underwriting Agreement, then, in each case, the Letter Agreement shall automatically terminate and be of no further force or effect and undersigned shall be released from all obligations under this Letter
Agreement, without any further action of any party hereto. The undersigned understands that the Underwriter is entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby consents to receipt of this Letter Agreement in electronic form and understands and agrees that this Letter Agreement
may be signed electronically. In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by electronic transmission (including any electronic signature complying with the U.S. federal ESIGN Act of 2000,<I>
e.g.</I>, www.docusign.com) evidencing an intent to sign this Letter Agreement, such facsimile transmission, electronic mail or other electronic transmission shall create a valid and binding obligation of the undersigned with the same force and
effect as if such signature were an original. Execution and delivery of this Letter Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and binding for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature page follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Letter Agreement and any claim, controversy or dispute arising under or related to this
Letter Agreement shall be governed by and construed in accordance with the laws of the State of New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name of Security Holder <I>(Print exact name)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">If not signing in an individual capacity:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name of Authorized Signatory <I>(Print)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title of Authorized Signatory <I>(Print)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d910663dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="6">


<IMG SRC="g910663dsp5.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Kelley Drye&nbsp;&amp; Warren LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">3 World Trade Center</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">175 Greenwich Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10007</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Tel: (212) <FONT STYLE="white-space:nowrap">808-7800</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fax: (212) <FONT STYLE="white-space:nowrap">808-7897</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">February&nbsp;13, 2026 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cineverse Corp. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">224 W. 35<SUP
STYLE="font-size:75%; vertical-align:top">th</SUP> St., Suite 500, #947 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10001 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We are acting as special
counsel to Cineverse Corp. a Delaware corporation (the &#8220;<U>Company</U>&#8221;), in connection with the preparation and filing with the Securities and Exchange Commission (the &#8220;<U>Commission</U>&#8221;) of a preliminary prospectus
supplement dated February&nbsp;12, 2026 filed with the Commission and a final prospectus (the &#8220;<U>Prospectus Supplement</U>&#8221;) to be filed thereafter with the Commission pursuant to Rule 424(b) promulgated under the Securities Act of
1933, as amended (the &#8220;<U>Act</U>&#8221;), which supplements the Company&#8217;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-273098</FONT> which was
declared effective on January&nbsp;25, 2024 (the &#8220;<U>Registration Statement</U>&#8221;) under the Act, relating to (a)&nbsp;the issuance and sale by the Company of shares of the Company&#8217;s Class&nbsp;A Common Stock, par value $0.001 per
share (the &#8220;<U>Common Stock</U>&#8221;), having an aggregate offering price of up to $3,000,000 (the &#8220;<U>Firm Shares</U>&#8221;) and (b)&nbsp;issuance and sale by the Company, at the option of the Underwriter, additional shares of Common
Stock having an aggregate offering price of up to $450,000 solely to cover over-allotments (the &#8220;<U>Optional Shares</U><I>&#8221; </I>and, together with the Shares, the &#8220;<U>Shares</U>&#8221;)<B><I> </I></B>that may be purchased by the
Underwriter upon its exercise of an option to purchase additional shares of Common Stock granted by the Company, to be issued pursuant to an Underwriting Agreement dated as of February 12, 2026, by and between the Company and The Benchmark Company,
LLC (the &#8220;<U>Underwriting Agreement</U>&#8221;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined and relied upon copies certified
or otherwise identified to our satisfaction of: (i)&nbsp;the Underwriting Agreement; (ii)&nbsp;the Registration Statement, together with exhibits and schedules thereto, and the Prospectus Supplement, each in the form filed with the Commission;
(iii)&nbsp;the Company&#8217;s Fifth Amended and Restated Certificate of Incorporation, as amended to date; (iv)&nbsp;the Company&#8217;s Second Amended and Restated <FONT STYLE="white-space:nowrap">By-Laws,</FONT> as amended to date; and
(v)&nbsp;the records of corporate proceedings of the Company relating to the Shares, as made available to us by officers of the Company; and have reviewed such matters of law as we have deemed necessary or appropriate for the purpose of rendering
this opinion. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g910663dsp5a.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;13, 2026 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this opinion we have assumed the authenticity of all documents submitted to
us as originals, the conformity to originals of all documents submitted to us as certified or photostatic copies, and the authenticity of the originals of all documents submitted to us as copies. We have also assumed the legal capacity of all
natural persons, the genuineness of all signatures on all documents examined by us, including signatures made and/or transmitted using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), and that any such
signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party&#8217;s handwritten signature. As to certain factual matters material to the opinion expressed herein, we have relied to the
extent we deemed proper upon representations, warranties and statements as to factual matters of officers and other representatives of the Company. Our opinion expressed below is subject to the qualification that we express no opinion as to any law
other than the General Corporation Law of the State of Delaware and the federal laws of the United States of America. Without limiting the foregoing, we express no opinion with respect to the applicability thereto or effect of municipal laws or the
rules, regulations or orders of any municipal agencies within any such state. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based upon and subject to the foregoing qualifications,
assumptions and limitations and the further limitations set forth below, it is our opinion that the Shares to be issued by the Company pursuant to the Underwriting Agreement have been duly authorized and, when issued and paid for in accordance with
the terms of the Underwriting Agreement, the Shares will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated
herein. We assume no obligation to revise or supplement this opinion should the present General Corporation Law of the State of Delaware or the federal laws of the United States of America be changed by legislative action, judicial decision or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this letter as an exhibit to the Registration Statement and to the reference to our firm
under the heading &#8220;Legal Matters&#8221; in the Prospectus Supplement. In giving such consent, we do not admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the
Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">This opinion is furnished to you in connection with the filing of the Registration Statement and is
not to be used, circulated, quoted or otherwise relied upon for any other purpose. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Kelley Drye&nbsp;&amp; Warren LLP</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>KELLEY DRYE&nbsp;&amp; WARREN LLP</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2</TD></TR></TABLE>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d910663dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g910663g0214001737972.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cineverse Announces Proposed Public Offering of Class&nbsp;A Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LOS ANGELES, February</B><B></B><B>&nbsp;12, 2026</B> &#8211; Cineverse Corp. (Nasdaq: CNVS) (&#8220;Cineverse&#8221;), an innovative and independent
entertainment technology company and studio, today announced a proposed underwritten public offering of shares of its Class&nbsp;A common stock (the &#8220;common stock&#8221;). Cineverse intends to grant the underwriter a <FONT
STYLE="white-space:nowrap">30-day</FONT> option to purchase up to an additional 15% of the number of shares of its common stock in the underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to
whether, or when, the offering may be completed or as to the actual size or terms of the proposed offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Benchmark Company, LLC is acting as the
sole underwriter for the proposed offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File No.&nbsp;333-273098)
relating to the shares was previously filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) and became effective on January&nbsp;25, 2024. The offering will be made only by means of a written prospectus and prospectus supplement
that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and available on the SEC&#8217;s website at <U>www.SEC.gov</U> once filed. A copy of
the preliminary prospectus supplement and accompanying prospectus, when available, may be obtained by contacting: The Benchmark Company, LLC, 150 East 58th Street, 17th Floor, New York, NY 10155, Attention: Prospectus Department, or by email
at&nbsp;<U>prospectus@benchmarkcompany.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release shall not constitute an offer to sell or the solicitation of an offer to buy these
securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Cineverse </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cineverse </B>(Nasdaq: CNVS) is
an entertainment technology company and studio. Fiercely innovative and independent, Cineverse develops and invests in technology and content that drives the future of the industry. Core to its business is Matchpoint<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> &#8211; a growing tech ecosystem powered by AI and designed to prepare, distribute, monetize, and continuously improve content across any platform. Matchpoint helps studios large and small
operate at scale and improve performance and efficiency in an increasingly fragmented distribution environment. Additionally, Cineverse distributes more than 71,000 premium films, series, and podcasts, across theatrical, home entertainment, and
streaming; operates dozens of digital properties that super serve passionate fandoms around the world; and works with leading brands to connect them with audiences they value. From award-winning technology to the highest-grossing unrated film in
U.S. history, Cineverse has created a playbook that marries tech and content to redefine the next era of entertainment. For more information, visit home.cineverse.com. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors and readers are cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral
statements of Cineverse officials during presentations about Cineverse, along with Cineverse&#8217;s filings with the Securities and Exchange Commission, including Cineverse&#8217;s registration statements, quarterly reports on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> and annual report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> are &#8220;forward-looking&#8217;&#8217; statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the
&#8220;Act&#8217;&#8217;). Forward-looking statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, which include words such as &#8220;expects,&#8221; &#8220;anticipates,&#8217;&#8217;
&#8220;intends,&#8217;&#8217; &#8220;plans,&#8217;&#8217; &#8220;could,&#8221; &#8220;might,&#8221; &#8220;believes,&#8217;&#8217; &#8220;seeks,&#8221; &#8220;estimates&#8217;&#8217; or similar expressions. In addition, any statements concerning
future financial performance (including future revenues, earnings, or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by Cineverse&#8217;s management, are also forward-looking statements as
defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and
the industries in which Cineverse does business, among other things. These statements are not guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For additional information, please contact: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For
Media </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Lippin Group for Cineverse </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cineverse@lippingroup.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>At Cineverse </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Julie Milstead </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@cineverse.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>d910663dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g910663g0213090102695.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Cineverse Announces Pricing of $3.0 Million Public Offering of Class&nbsp;A Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEW YORK, February</B><B></B><B>&nbsp;12, 2026</B> &#8211; Cineverse Corp. (Nasdaq: CNVS) (&#8220;Cineverse&#8221;), an innovative and independent
entertainment technology company and studio, today announced the pricing of a public offering of 1,500,000 shares of its Class&nbsp;A common stock (the &#8220;common stock&#8221;) at a public offering price of $2.00 per share. Cineverse granted the
underwriter a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to an additional 225,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to
Cineverse, before deducting underwriting discounts and commissions and other offering expenses payable by Cineverse, are expected to be approximately $3.0&nbsp;million, excluding any exercise of the underwriters&#8217; option to purchase additional
shares. The offering is expected to close on February&nbsp;17, 2026, subject to the satisfaction of customary closing conditions. The offering included participation from Cineverse Chairman and CEO Chris McGurk, along with other key members of
Cineverse&#8217;s management team. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Benchmark Company, LLC is acting as the sole underwriter for the proposed offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File No.&nbsp;333-273098) relating to the shares was previously filed with
the Securities and Exchange Commission (the &#8220;SEC&#8221;) and became effective on January&nbsp;25, 2024. The offering will be made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A
preliminary prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available on the SEC&#8217;s website at www.SEC.gov. A final prospectus supplement and accompanying prospectus relating to the
offering will be filed with the SEC and available on the SEC&#8217;s website at www.SEC.gov. A copy of the final prospectus supplement and the accompanying prospectus, when available, may be obtained by contacting: The Benchmark Company, LLC, 150
East 58th Street, 17th Floor, New York, NY 10155, Attention: Prospectus Department, or by email at&nbsp;prospectus@benchmarkcompany.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press
release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state or jurisdiction. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Cineverse </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cineverse </B>(Nasdaq: CNVS) is an entertainment technology company and studio. Fiercely innovative and independent, Cineverse develops and invests in
technology and content that drives the future of the industry. Core to its business is Matchpoint<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> &#8211; a growing tech ecosystem powered by AI and designed to prepare, distribute, monetize,
and continuously improve content across any platform. Matchpoint helps studios large and small operate at scale and improve performance and efficiency in an increasingly fragmented distribution environment. Additionally, Cineverse distributes more
than 71,000 premium films, series, and podcasts, across theatrical, home entertainment, and streaming; operates dozens of digital properties that super serve passionate fandoms around the world; and works with leading brands to connect them with
audiences they value. From award-winning technology to the highest-grossing unrated film in U.S. history, Cineverse has created a playbook that marries tech and content to redefine the next era of entertainment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors and readers are
cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral statements of Cineverse officials during presentations about Cineverse, along with Cineverse&#8217;s filings with the
Securities and Exchange Commission, including Cineverse&#8217;s registration statements, quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> and annual report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> are
&#8220;forward-looking&#8217;&#8217; statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8217;&#8217;). Forward-looking statements include statements that are predictive in nature, which depend upon
or refer to future events or conditions, which include words such as &#8220;expects,&#8221; &#8220;anticipates,&#8217;&#8217; &#8220;intends,&#8217;&#8217; &#8220;plans,&#8217;&#8217; &#8220;could,&#8221; &#8220;might,&#8221;
&#8220;believes,&#8217;&#8217; &#8220;seeks,&#8221; &#8220;estimates&#8217;&#8217; or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings, or growth rates), ongoing business
strategies or prospects, and possible future actions, which may be provided by Cineverse&#8217;s management, are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections
about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and the industries in which Cineverse does business, among other things. These statements are not
guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For additional information, please contact: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For
Media </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Lippin Group for Cineverse </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cineverse@lippingroup.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>At Cineverse </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Julie Milstead </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investorrelations@cineverse.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cnvs-20260212.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release merge Build:20260112.3 -->
<!-- Creation date: 2/14/2026 7:39:12 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:cnvs="http://cineverse.com/20260212"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://cineverse.com/20260212"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnvs-20260212_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnvs-20260212_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cnvs-20260212_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release merge Build:20260112.3 -->
<!-- Creation date: 2/14/2026 7:39:12 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cnvs-20260212_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release merge Build:20260112.3 -->
<!-- Creation date: 2/14/2026 7:39:12 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cnvs-20260212.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g910663dsp5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910663dsp5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !E )@# 1$  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z "@ H
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M87#8Z<9.+O[M]+KK=+L>QA\-E2X:QV,RJE.$9QM[]M>7JK-Z7;7J>2?LT?\
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M^TM#T&WT^^V&,3QLY(4XR.2?2LJ6$H49<U.-F88?+L)A9^THTU%G8UUGHA0
(4 % !0!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g910663dsp5a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910663dsp5a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  2 KX# 1$  A$! Q$!_\0
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M+^TU\/9_#&K^(K76FOM%TOPS#XNN+RVMW9?[.E-PJ2*,9+9M)P4QN&WD#(H
MLVGQ^\-ZKJ^HZ=I5EKNMS:>H%U+IFD3W$$4I@CN/(,JKM$OE31-M)_C ZG%
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M6\01:G<:KI^C0OX#FTK^SX+J:Y2Q\1>3Y-O?0RO&)'6..69#(S+(0J?+EF(
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M;:T>WN%TBXN4NM<7[.L,*7\##R&,6Q7$RD.2%7Y57Y@"35_@9XTTWPKX$O\
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MP.C^%=-O]5UEK'1+W^T)+&>X@6VM[*V>^M9 ]K'#+?9,B[@TR[0H V@$%_\
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M/0I+_;IEY>7,Q5CJMS;VYAE@N?-M90T18),LK*YW@$QC;D@'=ZO\*M4@\#>
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
, % !0 4 % !0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g910663g0213090102695.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910663g0213090102695.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !R 78# 2(  A$! Q$!_\0
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MI&#!)AOF&U1SP.N:^.Y?V_?V@EE<#XGZK@$C_50?_&Z]V_X)?_\ (I?'/_L
M?T:O@B?_ %\G^\?YTU%<ST ]_P#^&_\ ]H/_ **?JO\ WZ@_^-U^B'_!+O\
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M6D^_\+/IJ'_M"M:?Q(3/S%K]9/\ @C.BCX:>/V"C<=4@!..2/*-?DW7ZR_\
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M_>BBBBO/*"BBB@ HHHH **** "OS!_X+2??^%GTU#_VA7Z?5^8/_  6D^_\
M"SZ:A_[0K6G\2$S\Q:_67_@C/_R3'Q]_V%8?_11K\FJ_67_@C/\ \DQ\??\
M85A_]%&NBK\(D?HG1117$4?G_P#\%BO^2*^%?^PQ_P"TVK\AZ_7C_@L5_P D
M5\*_]AC_ -IM7Y#UVTOA)9]]?\$O_P#D4OCG_P!@#^C5\$3_ .OD_P!X_P Z
M^]_^"7__ "*7QS_[ ']&KX(G_P!?)_O'^=4OB8'TM_P3TT^/7/V@ET>9=\.H
MZ/?VSKZ@V[U\[:K92Z!K]W:2+LGLKEXF'HR,1_,5]._\$QE#_M=>&5/(-O=
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M(]D.K:?!<[L?><95OY+63_P3#_Y.]\+_ /7"Z_\ 1+5] _\ !9GPB4U7X?\
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M/<^45K*T?_@GE^S[HEPLT/PZLKAE.0MY<3SK^*NY!KZ-HI\S[@8GA+P1X?\
M 6E)IGAO1+#0M/3A;;3[=(4'X*!5OQ!X?TWQ7HMYI&L6,&I:7>1F&XM+E \<
MJ'JK*>HK0HJ0/&O^&-/@9_T2CPI_X+(_\*/^&-/@9_T2CPI_X+(_\*]EHIW?
M<#QK_AC3X&?]$H\*?^"R/_"O3/"'@W0_ 'A^UT+PWI5IHFC6N[R+&RB$<4>Y
MBS;5' R23^-;-%%VP"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g910663g0214001737972.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g910663g0214001737972.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !R 78# 2(  A$! Q$!_\0
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MI&#!)AOF&U1SP.N:^.Y?V_?V@EE<#XGZK@$C_50?_&Z]V_X)?_\ (I?'/_L
M?T:O@B?_ %\G^\?YTU%<ST ]_P#^&_\ ]H/_ **?JO\ WZ@_^-U^B'_!+O\
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M6D^_\+/IJ'_M"M:?Q(3/S%K]9/\ @C.BCX:>/V"C<=4@!..2/*-?DW7ZR_\
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M_>BBBBO/*"BBB@ HHHH **** "OS!_X+2??^%GTU#_VA7Z?5^8/_  6D^_\
M"SZ:A_[0K6G\2$S\Q:_67_@C/_R3'Q]_V%8?_11K\FJ_67_@C/\ \DQ\??\
M85A_]%&NBK\(D?HG1117$4?G_P#\%BO^2*^%?^PQ_P"TVK\AZ_7C_@L5_P D
M5\*_]AC_ -IM7Y#UVTOA)9]]?\$O_P#D4OCG_P!@#^C5\$3_ .OD_P!X_P Z
M^]_^"7__ "*7QS_[ ']&KX(G_P!?)_O'^=4OB8'TM_P3TT^/7/V@ET>9=\.H
MZ/?VSKZ@V[U\[:K92Z!K]W:2+LGLKEXF'HR,1_,5]._\$QE#_M=>&5/(-O=
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M(]D.K:?!<[L?><95OY+63_P3#_Y.]\+_ /7"Z_\ 1+5] _\ !9GPB4U7X?\
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M/<^45K*T?_@GE^S[HEPLT/PZLKAE.0MY<3SK^*NY!KZ-HI\S[@8GA+P1X?\
M 6E)IGAO1+#0M/3A;;3[=(4'X*!5OQ!X?TWQ7HMYI&L6,&I:7>1F&XM+E \<
MJ'JK*>HK0HJ0/&O^&-/@9_T2CPI_X+(_\*/^&-/@9_T2CPI_X+(_\*]EHIW?
M<#QK_AC3X&?]$H\*?^"R/_"O3/"'@W0_ 'A^UT+PWI5IHFC6N[R+&RB$<4>Y
MBS;5' R23^-;-%%VP"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
>444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 12, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001173204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 12,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cineverse Corp.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-3720962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">237 West 35th Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">#947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">206-8600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNVS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d910663d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cnvs-20260212.xsd</File>
    <File>cnvs-20260212_lab.xml</File>
    <File>cnvs-20260212_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d910663d8k.htm">d910663d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d910663d8k.htm": {
   "nsprefix": "cnvs",
   "nsuri": "http://cineverse.com/20260212",
   "dts": {
    "schema": {
     "local": [
      "cnvs-20260212.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cnvs-20260212_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnvs-20260212_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d910663d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-02-12_to_2026-02-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d910663d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-02-12_to_2026-02-12",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d910663d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cineverse.com//20260212/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-26-052164-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-052164-xbrl.zip
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MN\-D_1*W._W+WFPUP\;]_ U02P,$%     @ *JU-7"VV1_67!@  MTD  !4
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M-)4ECR2^_GTE@W8QF"PDVXZ5"SYDG:/WG$=6K(.N/ZQ2BA8@).&LY86UNH>
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M_0^ED.O@("<]W6!.+6^NF!=S!E>W_ M02P,$%     @ *JU-7'Y 6>U($@
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MCN<[1:/-S4;'H"[T3D]S7HA %'&K3P<LUQ.,?L6DJV.S&KWCP ^/0E/F0?B
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M)FW8MF!21K\NP=<UGJQ%3RJ@1$LGY O&IJ7*N0R7\73E[1E9%+A,/1B"<(3
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M#&W4;#X%$/$Y/4LBHC/X7]XEV9*""E?]G7G64&7 FG&&[/*RN7PJ)J9"Y:6
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MLD[UC+$,G.G4]@QG-;LL40$K6N/8Y$\T).#M+&*0;S#N:N6$IG_&A&_DF8D
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MFQB[#:% /NW% XCW)9O3=&XN</&&3<_0L/:<)PMJP08128Y/$*X.CAO^<>%
M23H)0%EMRHR1@M\F]2SYTVD4U140@\6LY^^[!&8]?AR=1N8S54P]#6T1;_ ^
M8&?92OL"ZJ&CF Y8U\\Q=EM%Y[LON"T9B/X0[\G%D._\B#*(>#4Q-2Q53Z%O
MKC%-L;"-> _VF7/6GT47,SA/LG69[>A"K_8+ZLDBI?VHQ;DO GM#DE0F'1_Z
M9)[-!]9UM_&M>)(/0.M_<J[JU@@J".(#BD0GUXR:9=*-7ZE;YIR::-&BGF$K
MC=>";AY4 Q.W.Z5Z?\RFD#XC,[Y8;P6EP9YXT5?XP+L="'@*K5YR^ /ESM8U
M3=8'J&7$NA2,>JI=ZSIC$V_FG%-T/-F/53.PGB%,[E*0R4Y?,PZ[9'CUY@E6
MXNU16V!-=+@ PYY=$=H_$?OU+J5Q(Q7@LR> V@[H('" KN\9?V)ZG\U2KC%A
M^EAA+59>)B#@IK#E6>/70Q7RJ;BFT/Z=I@7ZJ/SW"J>)=C70]V56>]=6E+F3
M-R"Z<4\)F>2"<@L1,[JSROUGW'_UK\#1YX'VJ4^C]XQ0>7&4G%+YTY0.[&*5
MD.J1TE]\*-JDS.<VV(JN_;";]J9BI4S3&NEK[&'+E;8.<)>ER$+\8N/1I%P5
M,W7H\\/^L:RR!;S&=>I3O!+R,'(+>]7/')17#]?R\K-=92TWBPSOJ7KC;'GM
MCK6!XIOK%-^JH!57KBN^C?:ZQ;<XO2^NMW4)U9V2O%L7R X6O;+#L1<'QO>!
MY006:J'C&W3["!K[WKJ1"&I\MU@$VL?6]FTXKC@)[S@ >+D=PL& B^.G*W&
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M;.&AFARQ2!-R3 $'3Z]%.G@]C;531(FI!65]5Z-.+M\%M<O!7W 5HS(*-LM
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MO"<2JDT.:M< H8Y]FTL'Z,P;@9QBE1,B5(?*,0U:0#10M*VF?)++/)$4'-U
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MG @PLKI?'X+/,'X+G 9.,WJ3-HB)(^ ML)Q?MV9X;6#UM]G"\>A55@/W/EW
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MO!XS-&J07,2@=Z#24*T8F<K?HU8;)+7T$&UR3B4%PH(9)UQKR'B^V"TD^/W
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M[TZ/AL>O(H\.Q7\OML]U=NF4*%ISJXD5@R(3*<D;/@>Y#YAUB??.]PX/]K^
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M/;*R<A,"12620X%&L"3= XI1"+FH#W%O7B4^,6Y8J\U8M>:((R.TY^P7BC5
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MA#^P+T<I"0@'::W6.\^JI!5R0\Z!S;$EY,5E]6 [,&\VN3LU)5H+\.M$.L&
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MY.!^YN [K F]:\/ATHVZ,?Y]S+C7=[9GKW,;UGF[-1D>-:MA4T9&[]Y[I49
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MZ#64-O',-*]JU_,I7H%*6WM5ZU:T B?LN^?#(]OF2WQ'KX-E]Y+%@"]$L]M
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M\J9^@0:^TJR\NJ+JYR;-/HPEPV;^J^O*.DB(;1_]=:YS =Q2*9@.$YA@AEY
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M'^$Y(2[X/4926;.::_,"<3CH!UZ&FD#:C 0+K\H?(FTR\1Q*!U@3MJ;5DM8
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MC=9$OJY[NF:PAW5,11MX_]+D!.2 ORPGIFX2WB0;D/ A!S81^2,/.01<IB5
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MU>U=7HV@PW[I.W]C8*3?T3OL!9]5K7[PMVT6ZJU\F_; __TWA$_$WE[]*S\
MW#U\\Z]XOG7>_@V6[=ZSSN"^N^;XL\&@>VT=?_XWOC%Y_DN3#51IK%3-OATQ
MW; M;3ML?].YQT/SZ>[_ %!+ P04    "  JK4U<8'T\C_(*   W'@  $0
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M*JH0R+8*)8R?L0'"P&CJY(;/*"M@5VT+59M0"VFT*EM=S5W3U4;L:^LMK*>
MH>^S@WZ[U^N1CS)99-1O,L"-17,3)?/,=1(#X>DI. *QYS@)MK397!,7:&:L
MWP3P0BM ':C9$2L=8%FB_Q"AW2=R!JA)/46CX/O\(@<5>"3IY!KNR0BY;HHC
M-1@I-QA'/!<&,IDT.?(*XL\;&UHOP#BA_(A C<.X@" JSZSGR!._AB-.PH^1
M>+=B"YX6 H5D-+C$DIND@PQ359*515%V_3D&>Y1,9T9^H"6%(LL2[S:$:GOK
M4W?2Q3*, F;#^1@O& 72A5DJY:M(ZYM@-'#%> ]04F^4'Z%L(J8X)<P?XIMC
M\"5Y<,/G7:*5(:A2^7RB!&BSA02_\#'JQI4JU"9#BR2</3W_#-@K;U PW_O_
MASFR>96*3>05V1T(I%<YGXE.!--N.I& ;#'@Z9*O; M0NI.3D'<?V>3\7RC[
MO59UKK_A&?QPZ/]KL=_.3Z_?O6[U>[UG]17 R?CR>OSQ_^Z.AU!\PJ>"O>,F
M@M,G-;G_#]<+3])"SCUD:Q, '$Y'EZ6RH,G00P$A'N54'))C38%MH'2>W_D1
M55(]QD59LD1&02[PVU)%-[9A,6I2:G3G3<X3=/#+M>$IE7R]B>YAZMS7'M-X
M"H&%"5P4;$4%JH%3-CLQE$FU)]:HU8U;#L^946DXPOZ9<:9-()H6'ACN'GC_
MQ "T Z$QR#G +OJ'-F35QOCVZ%5#O]?Y1S7!>2ZN% W8X:3_?@[$,;^VZW-,
M/92ASCQ4@6+?P*S2F/)7,WKDIO)&@F:M\HJ&'C^@K1.V-OQW@5^SX(B/P@]7
MQ[&?K/J'A_M^*-S>*A7 ATVA+SP&-97:3"(*P$9>^30EDY -GODM"+P8\+Z@
M7AT(:B QK,@#QS2B9,DE$4$H?;:9C>N2L+42B>Z0V$ WD=VE^N(;#1&V74ZV
MU6L.%A#+G)I5>].\VO#R)NK6Y^H  +MZZ%M,7/JVQ(RNBF^_C##=P;2'#K)"
MW-Q1'; @,U+\UAYB\A@5P4H8C*;Z)2=UV?GZDJN]'A5JI !^4+)L;Y6>1@\"
M1Y'4LAN,Y?FZL,IUAD)2$'40W)]@_2Q'O WUZFG "[Q1,^W;=,45?0&B$(4/
M9C7DU00$2M,(7<K@\4:@R^F5^)1, @F\6^70%WVJ!#LZ([6:31].6 XN'CJO
M/Y *!BG_:([3L1'W]TV*H:8,-860:!72A?L,NNEK(-]F+GNPP&/C1G#!#=WD
M,(Q(B#NC"UD/[JZF:'09F.4/P"F1\C65:1-M5CH#FM/.\K9Q"I^BJY3<K4'N
MRUDR>+K!);58,WWLR@BQ-8VFU%D0=7_Y8\5M_]" / .NHM!$N#\MK6]D53!I
M+<N/DH[?8+W"' U_TIC)=)168(64\659W><6>4+(YNYH,'7E4.J_>R"4=3_[
M/G,G$;7&[?(&7<O#74)Y]S+X3C,I--K>>@\,YM]#(%TF7<@\1U*]!9O/_6UM
M<RQ^]%^V_K+XF@;_G'HE9J0#4>+'+HV>[,[AO@N'OY,N_E*@D;#W,L64S)-'
M3'P2W\J2G(:[4F#1SQM#QR,S!WQQ=?H%+_T_&/\;4$L#!!0    ( "JM35Q4
M(-4>F L  %\@   1    9#DQ,#8V,V1E>#DY,BYH=&W-6FMSVS86_:X9_0>,
MNMM)9BA9LM=)+"N:.HZ<N'7LK.VVF_T&DI"$F@18 +2B_OH]%R IRH^DW;H[
MV\G$(0C>]SWWX4[>7W\XFT[>SX[>3KN=R?7I]=EL.OM7_^!@L#O9"8\XWZDN
ML,F;B[>?V)MWQQ=G%Y>O>S^_/[V>]=C5]:>SV>M>)I7H+X5<+-WX7)N<9[TI
MZW;P_;%03ICIY.WI3_7EE4S=<OQJL"]5C_%,+A0(B+GK>38?ZVLY-PNI^DX7
MXV'A#EGU'&OG=!Z.YEJYOI6_B?%H\SSGN<S6XVN9"\O.Q8I=ZIR#T]'9Z;OS
MUSU#0O:FDS?3V>>EC*5CI#&;[+R93G8^3EL"M*CO@OH=>>Z)TYM^JV);'!(5
M*/Z8'O>_JR5+O*G("MYRIQ_>L:O+X]>]Q<%H^.+%WF*X.]H;'@Q'P]T7!_N#
M7XH%?7G]NG=V\>XBV&Y;_A9CK\!36;"6$R8\AM]OA;&"'2FE2Y7@@X]&)E(M
MF)ZSO^T-ANR#S#*I%?M8QIE,V,5\+DSU_CCCU@:K';%CG>>X=N5T<M.XXQ%#
M/HD^I,#Y[&?VZ>+RAXB=B-B4W*P]9V+N?P3A1KL1VX79Z9!]^\VKW='HD&UT
M/]:F&+!GY]RF_-<Q.S[_Z>HY>T;W=H>'S37_/#I\'C&NF(2Y;KF3MP)/*1Y3
M40C\I5RWX\WKN%0Y_L6<2)9*9WJQ9HG."Z[6_@OKRE3JB#F=<CH)UD^96PI6
M;#S 61',KEMF'T7[PV$T' Z977(#F^!,.KOMCB2XPWIW/".RE4+M%[5.C+L'
M6)$<PL?![@#,"F$"PT'+=@O#H:Z7N]LI80&S,A+Z@]SDY.+\N@&-)4[[MN")
M&"N],KSH3?>&?2@_V:%[4Z8+1V'F-.0PR9*#>%G0(\S-TU326YZQW=W].ZIO
M:0I%O D?4B5BF;"6-5+2BU3:!*:']<@K1$I:"TYVP*Z7I)[&%X71B1"I97.C
M<T^_(>QTM]-8(V*QF&LC6"K2,O'T?Q\S_ZQ!V&PHB\^(* L5"[[F<298O&8M
M3M#>7TF\]34X,UY T,\RYTYD:Y^\(1CRD,$1[B<9P@[$*0S%9V$2:;V'2:>6
M]ZQ/DI>'#SEEXXMN)S@AF*H17-HMP9),$P_59&B5DR]#3D;,EO$ON$UW20R+
MM+)SGGC&Y-X2G@54K#TE8I!H%42XQUF1?F!;<..00P7W1+S76NF^Y!(E3GFC
M'\\N<& @\X?D76EN8-A,@]1*NF7ED1NQ9KG(8WP,5BUW5T:R #+%%Z)*=YX/
M_FHDGY+6;X1*EB!T0\A+N!*QL[-CLCX/H<=ML*?.MGP+RJ:"&5W -6ECOR#W
M(Y#]XBGD/D+:BFS.C%A(ZTQPCW4(6&\\"A)T'U]'CJO^7@T;STXD]#O7@Q!6
M>WM[_=V7J+.OGH-+QEU(TF") !DK3ADM;J4N+?)DCN]3[^]NAVY=B:2D?!4A
M*V>?$?9J(7Q]"^FZ!:=7L^,-BN)^+!*>(S5AT\37!]S_GJM-X ._*/#_<2=V
M5TA22N*<I_0-!(LI[+BRH0Z0\YQ0Y#5+R54&\5J/MBR*K(K")7!P3J;D/A?J
M%'_8[@-VU.W (IG,I:)$>Y@HL>-)5<0"J#;7[IJZ40N0 :T@]\;,_@+,%BHG
MU+CE,O,(1T@3WC6IM1*QA?\)UU>KU0"O!@M]"XE!D,K!GQ:UV[GG@D=$_2_E
M3'2QKNW_-9GISB-R1VRUA!D;(2)$RIJDU3'U&A XI@Y#N9#]8_8X1D1LM#_L
M=F;<.K;_"EI>.2.$P_%+/)QD6IO(9^TG38!X_HF-AJ-]A.T112#%SAA=8J/#
M6T$A1CI$#- ",40.(6&*$/ ;';Z+:WDJ%0?X^;] 2^DSWMIN!]X75,6 !7"V
MTHYL9IUT)3E/A<"ET+ "[RND!(2BFCA>EZ3VO;A<TQTBV0!'!,*F8D$E1/CJ
MC))K>5:7VZT/4+G">TI)XOH+7MA4AB*(EP#!9(EHP5^><W1')A-(KW29$00!
M[S.^FI<4:Y*4T*1Y*_=Q]FN)V6TNDW#@"T10=B,5: 3T(=&(]X/R-65C!T,B
M&N]J9,1 X_],"GRVSL2V8T5^SZ]T5*".]F,C^$T_M%)CGJWXVF(<G>P4Q.3]
M);LZ_3?"9*]7T_4C[?B; _]?C_U\^O;Z_>O>:#C\>S/S',_.KV>7_W=#+8TH
M1[$N7:L]^<KH]"1U>&OT(X9WAA]"9<7^P" S8"<2W23UG8^/1E%+RQ0_,UW8
MZLZML(ZR "5XPR8TR<HU%2TUH!JZFGGI2M.TKF""+M&L!S3+"4I+FH?B$NTB
M=?S4W7&7+ LME9M<_?C BN#E_M\/&41#V\BSO@^ ,<S=FWZ+O#F<[."CS>C(
M:2Y8^1H":9E(M%U;U%)6Z!6RW4/QT:F7/Q46I$(G# @"4@*Y4TI$&0-R@.):
M"0<)HFZGUE>J,K0F,@=VPHZU$7CBQQ$R?8$B1@5^T-*,H;>"18-'*'O-(OC
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M#P  9#DQ,#8V,V0X:RYH=&U02P$"% ,4    "  JK4U<^QBY4@^4  #FOP(
M$               @ &I(0  9#DQ,#8V,V1E>#$Q+FAT;5!+ 0(4 Q0    (
M "JM35PX*F ).0P  ,$K   0              "  >:U  !D.3$P-C8S9&5X
M-3$N:'1M4$L! A0#%     @ *JU-7&!]/(_R"@  -QX  !$
M ( !3<(  &0Y,3 V-C-D97@Y.3$N:'1M4$L! A0#%     @ *JU-7%0@U1Z8
M"P  7R   !$              ( !;LT  &0Y,3 V-C-D97@Y.3(N:'1M4$L%
3!@     (  @ ^P$  #79      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d910663d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cnvs-20260212.xsd" xlink:type="simple"/>
    <context id="duration_2026-02-12_to_2026-02-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001173204</identifier>
        </entity>
        <period>
            <startDate>2026-02-12</startDate>
            <endDate>2026-02-12</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-296">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-02-12_to_2026-02-12"
      id="Hidden_dei_EntityCentralIndexKey">0001173204</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-307">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-308">2026-02-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-309">Cineverse Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-310">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-311">001-31810</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-312">22-3720962</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-75">237 West 35th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-313">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-314">#947</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-315">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-316">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-317">10001</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-318">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-319">206-8600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-320">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-321">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-322">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-323">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-324">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-325">CLASS A COMMON STOCK, PAR VALUE $0.001 PER SHARE</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-326">CNVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2026-02-12_to_2026-02-12" id="ixv-327">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
